Sex hormones and their analogues in neuroimmune biology

Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry

Volumn 10, Issue 3, 2010, Pages 142-181

  Berczi, Istvan ^a   Laatikainen, Reino ^b   Pulkkinen, Juha ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Autoimmune; Immune function; Inflammatory and infectious diseases; Neuroimmune biology; Sex hormones

Indexed keywords

17ALPHA ETHYNYL 5 ANDROSTENE 3BETA, 7BETA, 17BETA TRIOL; 6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL]BENZO[B]THIOPHENE; ANDROGEN; CHORIONIC GONADOTROPIN; DIENOGEST PLUS ESTRADIOL VALERATE; DIETHYLSTILBESTROL; ERA 63; ESTETROL; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; FOLLITROPIN; FULVESTRANT; GONADORELIN; GONADORELIN[1-9] ETHYLAMIDE[6 DEXTRO ALANINE]; HALOPERIDOL; HE 3286; KISSPEPTIN; LEUPRORELIN; METOCLOPRAMIDE; PRASTERONE; PRINABEREL; PROGESTERONE DERIVATIVE; PROLACTIN; PROLACTIN DERIVATIVE; RALOXIFENE; SEX HORMONE; TAMOXIFEN; TESTOSTERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; AGING; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; BLOOD BRAIN BARRIER; BONE MARROW; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DIARRHEA; DRUG MECHANISM; DRUG POTENCY; ENDOTHELIUM; EXERCISE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; INJURY; INNATE IMMUNITY; LYMPHOID CELL; LYMPHOID ORGAN; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PREGNANCY; PROLACTINOMA; REPRODUCTION; SCHIZOPHRENIA; STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS; TESTIS; THYMUS; ULCERATIVE COLITIS; UTERUS;

EID: 78649264205     PISSN: 18715222     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152210793292597     Document Type: Article

References (457)

1. Hammar, J.A. The new views as to the morphology of the thymus gland and their bearing on the problem of the function of the thymus. Endocrinology, 1921, 5, 543-573, 731-760.
2. Smith, P.E. Effect of hypophysectomy upon the involution of the thymus in rat. Anat. Rec., 1930, 47, 119-129.
3. Korneva, E. On the history of Immunophysiology. First steps and main trends. In: New Insights to Neuroimmune Biology, Elsevier, Amsterdam, 2010, pp 33-50. Elsevier, Insights. www.amazon.com
4. Filipp, G.; Szentivanyi, A.; Mess, B. Anaphylaxis and nervous system. Acta Med. Hung., 1952, 2, 163-173.
5. Szentivanyi, A.; Filipp, G. Anaphylaxis and the nervous system Part II. Ann. Allergy, 1958, 16, 143-151.
6. Filipp, G.; Szentivanyi, A. Anaphylaxis and the nervous system. Part III. Allergy, 1958, 16, 306-311.
7. Szentivanyi, A.; Szekely, J. Effect of injury to, and electrical stimulation of, hypothalamic areas on anaphylactic and histamine shock of the guinea pig. A preliminary report. Ann. Allergy, 1956, 14, 259-261.
8. Korneva, E.A.; Khai, L.M. Effect of destruction of hypothalamic areas on immunogenesis. Fed. Proc. 1964, 23, T88.
9. Selye, H. A syndrome produced by diverse nocuous agents. Nature (Lond), 1936, 138, 32.
10. Selye, H. Thymus and adrenals in the response of the organism to injuries and intoxication. Br. J. Exp. Path., 1936, 17, 234-248.
11. Selye, H. Morphological changes in the fowl following chronic over-dosage with various steroids. J. Morphol., 1943, 73, 401-421.
12. Selye, H. The general adaptation syndrome and the diseases of adaptation. J. Clin. Endocrinol., 1946, 6, 117-230.
13. Marchetti, B.; Gallo, F.; Farinella, Z.; Tirolo, C.; Testa, N; Caniglia, S.; Morale, M.C. Gender, neuroendocrine-immune interactions and neuron-glial plasticity. Role of luteinizing hormone-releasing hormone (LHRH). Ann. NY Acad. Sci., 2000, 917, 678-709.
14. Dozio, E.; Ruscica, M.; Galliera, E.; Corsi, M.M.; Magni, P. Leptin, ciliary neurotrophic factor, leukemia inhibitory factor and interleukin-6: class-I cytokines involved in the neuroendocrine regulation of reproductive function. Curr. Protein Pept. Sci., 2009, 10, 577-584.
15. Farkas, I.; Varju, P.; Szabo, E.; Hrabovszky, E.; Okada, N.; Okada, H.; Liposits, Z. Estrogen enhances expression of the complement C5a receptor and the C5a-agonist evoked calcium influx in hormone secreting neurons of the hypothalamus. Neurochem. Int., 2008, 52, 846-856.
16. Lourenço, G.A.; Dorce, V.A.; Palermo-Neto, J. Haloperidol treatments increased macrophage activity in male and female rats: influence of corticosterone and prolactin serum levels. Eur. Neuro-psychopharmacol., 2005, 15, 271-277.
17. Hollis, J.H.; Lightman, S.L.; Lowry, C.A. Lipopolysaccharide has selective actions on sub-populations of catecholaminergic neurons involved in activation of the hypothalamic-pituitary-adrenal axis and inhibition of prolactin secretion. J. Endocrinol., 2005, 184, 393-406.
18. Cocco, C.; Meloni, A.; Boi, F.; Pinna, G.; Possenti, R.; Mariotti, S.; Ferri, G.L. Median eminence dopaminergic nerve terminals: a novel target in autoimmune polyendocrine syndrome? J. Clin. Endocrinol. Metab., 2005, 90, 4108-4111.
19. Tanriverdi, F.; Gonzalez-Martinez, D.; Silveira, L.F.; Hu, Y.; Maccoll, G.S.; Travers, P.; Bouloux, P.M. Expression of gonadotropin-releasing hormone type-I (GnRH-I) and type-II (GnRH-II) in human peripheral blood mononuclear cells (PMBCs) and regulation of B-lymphoblastoid cell proliferation by GnRH-I and GnRH-II. Exp. Clin. Endocrinol. Diabetes, 2004, 112, 587-594.
20. Seth, A.; Stanley, S.; Jethwa, P.; Gardiner, J; Ghatei, M.; Bloom, S. Galanin-like peptide stimulates the release of gonadotropin-releasing hormone in vitro and may mediate the effects of leptin on the hypothalamo-pituitary-gonadal axis. Endocrinology, 2004, 145, 743-750.
21. Jacobson, J.D.; Ansari, M.A. Immunomodulatory actions of gonadal steroids may be mediated by gonadotropin-releasing hormone. Endocrinology, 2004,145, 330-336.
22. Jacobson, J.D. Gonadotropin-releasing hormone and G proteins: potential roles in autoimmunity. Ann. NY Acad. Sci., 2000, 917, 809-818.
23. Dixit, V.D.; Yang, H.; Udhayakumar, V.; Sridaran, R. Gonadotropin-releasing hormone alters the T helper cytokine balance in the pregnant rat. Biol. Reprod., 2003, 68, 2215-2221.
24. Williams, C.Y.; Harris, T.G.; Battaglia, D.F.; Viguié, C.; Karsch, F.J. Endotoxin inhibits pituitary responsiveness to gonadotropin-releasing hormone. Endocrinology, 2001, 142, 1915-1922.
25. Jacobson, J.D.; Crofford, L.J.; Sun, L.; Wilder, R.L. Cyclical expression of GnRH and GnRH receptor mRNA in lymphoid organs. Neuroendocrinology, 1998, 67, 117-125.
26. Tanriverdi, F.; Silveira, L.F.; MacColl, G.S.; Bouloux, P.M. The hypothalamic-pituitary-gonadal axis: immune function and auto-immunity. J. Endocrinol., 2003, 176, 293-304.
27. Dixit, V.D.; Sridaran, R.; Edmonsond, M.A.; Taub, D.; Thompson, W.E. Gonadotropin-releasing hormone attenuates pregnancy-associated thymic involution and modulates the expression of anti-proliferative gene product prohibitin. Endocrinology, 2003, 144, 1496-1505.
28. Raga, F.; Casañ, E.M.; Bonilla-Musoles, F. Gonadotropin-releasing hormone (GnRH)-I regulation of interleukin (IL)-1b and IL-1 receptor antagonist expression in cultured human endometrial stromal cells. 19. J. Obstet. Gynaecol. Res., 2008, 34, 464-472.
29. Umathe, S.N.; Dixit, P.V.; Wanjari, M.M.; Ullewar, M.P. Leuprolide--a GnRH agonist--prevents restraint stress-induced immuno-suppression via sex steroid-independent peripheral mechanism in mice. Int. Immunopharmacol., 2008, 8, 71-79.
30. Bobyntsev II, Sever'yanova, L.A. Immunotropic effects of gonadotropin-releasing hormone analog under conditions of emotional painful stress. Bull. Exp. Biol. Med., 2002, 133, 436-438.
31. Mann, D.R.; Akinbami, M.A.; Lunn, S.F.; Fraser, H.M.; Gould, K.G.; Ansari, A.A. Endocrine-immune interaction: alterations in immune function resulting from neonatal treatment with a GnRH antagonist and seasonality in male primates. Am. J. Reprod. Immunol., 2000, 44, 30-40
32. Iwasa, T.; Matsuzaki, T.; Murakami, M.; Shimizu, F.; Kuwahara, A.; Yasui, T.; Irahara, M. Decreased expression of kisspeptin mediates acute immune/inflammatory stress-induced suppression of gonadotropin secretion in female rat. J. Endocrinol. Invest., 2008, 31, 656-659.
33. Komine-Aizawa, S.; Majima, H.; Yoshida-Noro, C.; Hayakawa, S. Stimuli through Toll-like receptor (TLR) 3 and 9 affect human chorionic gonadotropin (hCG) production in a choriocarcinoma cell line. J. Obstet. Gynaecol. Res., 2008, 34, 144-151.
34. Kayisli, U.A.; Selam, B.; Guzeloglu-Kayisli, O.; Demir, R.; Arici, A. Human chorionic gonadotropin contributes to maternal immuno-tolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J. Immunol., 2003, 171, 2305-2313.
35. Csaba, G.; Pállinger, E. In vitro effect of hormones on the hormone content of rat peritoneal and thymic cells. Is there an endocrine network inside the immune system? Inflamm. Res., 2007, 56, 447-451.
36. Mills, S.C.; Hazard, L.; Lancaster, L.; Mappes, T.; Miles, D.; Oksanen, T.A.; Sinervo, B. Gonadotropin hormone modulation of testosterone, immune function, performance, and behavioral trade-offs among male morphs of the lizard Uta stansburiana. Am. Nat., 2008, 171, 339-357
37. Shirshev, S.V.; Kuklina, E.M.; Yarilin, A.A. Role of reproductive hormones in control of apoptosis of T-lymphocytes. Biochemistry (Mosc.), 2003, 68, 470-475.
38. Segerer, S.E.; Müller, N.; van den Brandt, J.; Kapp, M.; Dietl, J.; Reichardt, H.M.; Rieger, L.; Kämmerer, U. Impact of female sex hormones on the maturation and function of human dendritic cells. Am. J. Reprod. Immunol., 2009, 62, 165-173.
39. Schumacher, A.; Brachwitz, N.; Sohr, S.; Engeland, K.; Langwisch, S.; Dolaptchieva, M.; Alexander, T.; Taran, A.; Malfertheiner, S.F.; Costa, S.D.; Zimmermann, G.; Nitschke, C.; Volk, H.D.; Alexander, H.; Gunzer, M.; Zenclussen, A.C. Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J. Immunol., 2009, 182, 5488-5497.
40. Wan, H.; Coppens, J.M.; van Helden-Meeuwsen, C.G.; Leenen, P.J.; van Rooijen, N.; Khan, N.A.; Kiekens, R.C.; Benner, R.; Versnel, M.A. Chorionic gonadotropin alleviates thioglycollate-induced peritonitis by affecting macrophage function. J. Leukoc. Biol., 2009, 6, 361-370.
41. Kane, N.; Kelly, R.; Saunders, P.T.; Critchley, H.O. Proliferation of uterine natural killer cells is induced by human chorionic gonadotropin and mediated via the mannose receptor. Endocrinology, 2009, 150, 2882-2888.
42. Wan, H.; Versnel, M.A.; Leijten, L.M.; van Helden-Meeuwsen, C.G.; Fekkes, D.; Leenen, P.J.; Khan, N.A.; Benner, R.; Kiekens, R.C. Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype. J. Leukoc. Biol., 2008, 83, 894-901.
43. Kosaka, K.; Fujiwara, H.; Tatsumi, K.; Yoshioka, S.; Sato, Y.; Egawa, H.; Higuchi, T.; Nakayama, T.; Ueda, M.; Maeda, M.; Fuji, S. Human chorionic gonadotropin (HCG) activates monocytes to produce interleukin-8 via a different pathway from luteinizing hormone/HCG receptor system. J. Clin. Endocrinol. Metab., 2002, 87, 5199-5208.
44. Gloddek, J.; Lohrer, P.; Stalla, J.; Arzt, E.; Stalla, G.K.; Renner, U. The intrapituitary stimulatory effect of lipopolysaccharide on ACTH secretion is mediated by paracrine-acting IL-6. Exp. Clin. Endocrinol. Diabetes, 2001, 109, 410-415.
45. Breuel, K.F.; Kougias, P.; Rice, P.J.; Wei, D.; De Ponti, K.; Wang, J.; Laffan, J.J.; Li, C.; Kalbfleisch, J.; Williams, D.L. Anterior pituitary cells express pattern recognition receptors for fungal glucans: implications for neuroendocrine immune involvement in response to fungal infections. Neuroimmunomodulation, 2004, 11, 1-9.
46. Mavoungou, D.; Poaty-Mavoungou, V.; Ongali, B.; Akoume, M.Y.; Maka, G.; Mavoungou, E. Hypothalamic-pituitary gonadal axis and immune response imbalance during chronic filarial infections. Trop. Med. Int. Health., 2005, 10, 1180-1186.
47. Morale, M.C.; Gallo, F.; Tirolo, C.; L'Episcopo, F.; Gennuso, F.; Testa, N.; Caniglia, S.; Spina-Purrello, V.; Avola, R.; Scoto, G.M.; Marchetti, B. The reproductive system at the neuroendocrine-immune interface: focus on LHRH, estrogens and growth factors in LHRH neuron-glial interactions. Domest. Anim. Endocrinol., 2003, 25, 21-46.
48. Watanobe, H.; Habu, S. Ciliary neurotrophic factor, a gp130 cytokine, regulates preovulatory surges of luteinizing hormone and prolactin in the rat. Neuroendocrinology, 2001, 74, 281-287.
49. Iwasa, T.; Matsuzaki, T.; Murakami, M.; Kinouchi, R.; Ogata, R.; Kuwahara, A.; Yasui, T.; Irahara, M. Neonatal lipopolysaccharide exposure attenuates the homotypic stress-induced suppression of LH secretion in adulthood in male rat. Int. J. Dev. Neurosci., 2009, 27, 345-349
50. Sirivelu, M.P.; Shin, A.C.; Perez, G.I.; MohanKumar, P.S.; MohanKumar, S.M. Effect of L-dopa on interleukin-1 beta-induced suppression of luteinizing hormone secretion in intact female rats. Hum. Reprod., 2009, 24, 718-725.
51. Sirivelu, M.P.; Burnett, R.; Shin, A.C.; Kim, C.; MohanKumar, P.S.; MohanKumar, S.M. Interaction between GABA and norepinephrine in interleukin-1beta-induced suppression of the luteinizing hormone surge. Brain Res., 2009, 1248, 107-114.
52. Iqbal, J.; Sun, L.; Kumar, T.R.; Blair, H.C.; Zaidi, M. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc. Natl. Acad. Sci. USA, 2006, 103, 14925-14930.
53. Hooghe, R.; Dogusan, Z.; Martens, N.; Velkeniers, B.; Hooghe-Peters, E.L. Effects of prolactin on signal transduction and gene expression: possible relevance for systemic lupus erythematosus. Lupus, 2001, 10, 719-727.
54. Yu-Lee, L.Y. Prolactin modulation of immune and inflammatory responses. Recent Prog. Horm. Res., 2002, 57, 435-455.
55. Walenkamp, M.J.; Vidarsdottir, S.; Pereira, A.M.; Karperien, M.; van Doorn, J.; van Duyvenvoorde, H.A.; Breuning, M.H.; Roelfsema, F.; Kruithof, M.F.; van Dissel, J.; Janssen, R.; Wit, J.M.; Romijn, J.A. Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation. Eur. J. Endocrinol., 2007, 156, 155-165.
56. Tomio, A.; Schust, D.J.; Kawana, K.; Yasugi, T.; Kawana, Y.; Mahalingaiah, S.; Fujii, T.; Taketani, Y. Prolactin can modulate CD4+ T-cell response through receptor-mediated alterations in the expression of T-bet. Immunol. Cell Biol., 2008, 86, 616-621.
57. Gerlo, S.; Verdood, P.; Kooijman, R. Tumor necrosis factor-alpha activates the extrapituitary PRL promoter in myeloid leukemic cells. J. Neuroimmunol., 2006, 172, 206-210.
58. Yang, H.; Dixit, V.D.; Patel, K.; Vandanmagsar, B.; Collins, G.; Sun, Y.; Smith, R.G.; Taub, D.D. Reduction in hypophyseal growth hormone and prolactin expression due to deficiency in ghrelin receptor signaling is associated with Pit-1 suppression: relevance to the immune system. Brain. Behav. Immun., 2008, 22, 1138-1145.
59. Dogusan, Z.; Hooghe, R.; Verdood, P.; Hooghe-Peters, E.L. Cytokine-like effects of prolactin in human mononuclear and polymor-phonuclear leukocytes. J. Neuroimmunol., 2001, 120, 58-66.
60. Kooijman, R.; Gerlo, S.; Coppens, A.; Hooghe-Peters, E.L. Growth hormone and prolactin expression in the immune system. Ann. N. Y. Acad. Sci., 2000, 917, 534-540.
61. Motta, M.; Accornero, P.; Baratta, M. Leptin and prolactin modulate the expression of SOCS-1 in association with interleukin-6 and tumor necrosis factor-alpha in mammary cells: a role in differentiated secretory epithelium. Regul. Pept., 2004, 121, 163-170.
62. Xiao, E.; Xia-Zhang, L.; Vulliémoz, N.R.; Ferin, M.; Wardlaw, S.L. Agouti-related protein stimulates the hypothalamic-pituitary-adrenal (HPA) axis and enhances the HPA response to interleukin-1 in the primate. Endocrinology, 2003, 144, 1736-1741.
63. Imrich, R.; Tibenska, E.; Koska, J.; Rovensky, J.; Vigas, M. Pharmacological hyperprolactinemia attenuates hydrocortisone-induced expression of CD11b on human CD8+ cells in vivo. Neuroimmunomodulation, 2004, 11, 133-140.
64. Tripathi, A.; Sodhi, A. Prolactin-induced production of cytokines in macrophages in vitro involves JAK/STAT and JNK MAPK pathways. Int. Immunol., 2008, 20, 327-336.
65. Carvalho-Freitas, M.I.; Rodrigues-Costa, E.C.; Nasello, A.G.; Palermo-Neto, J.; Felicio, L.F. In vitro macrophage activity: biphasic effect of prolactin and indirect evidence of dopaminergic modulation. Neuroimmunomodulation, 2008, 15, 131-139.
66. Sodhi, A.; Tripathi, A. Prolactin and growth hormone induce differential cytokine and chemokine profile in murine peritoneal macrophages in vitro: involvement of p-38 MAP kinase, STAT3 and NF-kappaB. Cytokine, 2008, 41, 162-173.
67. Malaguarnera, L.; Imbesi, R.M.; Scuto, A.; D'Amico, F.; Licata, F.; Messina, A.; Sanfilippo, S. Prolactin increases HO-1 expression and induces VEGF production in human macrophages. J. Cell. Biochem., 2004, 93, 197-206.
68. Malaguarnera, L.; Musumeci, M.; Licata, F.; Di Rosa, M.; Messina, A.; Musumeci, S. Prolactin induces chitotriosidase gene expression in human monocyte-derived macrophages. Immunol. Lett., 2004, 94, 57-63.
69. Yang, L.; Hu, Y.; Li, X.; Zhao, J.; Hou, Y. Prolactin modulates the functions of murine spleen CD11c-positive dendritic cells. Int. Immunopharmacol., 2006, 6, 1478-1486.
70. Zhang, J.; Sun, R.; Tian, Z. Human prolactin promotes human secondary immunoglobulin response in human/SCID mouse chimeras. Clin. Vaccine Immunol., 2007, 14, 60-64.
71. Saha, S.; Gonzalez, J.; Rosenfeld, G.; Keiser, H.; Peeva, E. Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum., 2009, 60, 1743-1752.
72. Krishnan, N.; Thellin, O.; Buckley, D.J.; Horseman, N.D.; Buckley A.R. Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology, 2003, 144, 2102-2110.
73. Peeva, E.; Michael, D.; Cleary, J.; Rice, J.; Chen, X.; Diamond, B. Prolactin modulates the naive B cell repertoire. J. Clin. Invest., 2003, 111, 275-283.
74. Gutiérrez-Barroso, A.; Anaya-López, J.L.; Lara-Zárate, L.; Loeza-Lara, P.D.; López-Meza, J.E.; Ochoa-Zarzosa, A. Prolactin stimulates the internalization of Staphylococcus aureus and modulates the expression of inflammatory response genes in bovine mammary epithelial cells. Vet. Immunol. Immunopathol., 2008, 121, 113-122.
75. Brand, J.M.; Frohn, C.; Cziupka, K.; Brockmann, C.; Kirchner, H.; Luhm, J. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur. Cytokine Netw., 2004, 15, 99-104.
76. Hassan, M.I.; Waheed, A.; Yadav, S.; Singh, T.P.; Ahmad, F. Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications. Cell. Mol. Life Sci., 2009, 66, 447-459.
77. Takizawa, K.; Kitani, S.; Takeuchi, F.; Yamamoto, K. Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin. Endocr. J., 2005, 52, 635-641.
78. Breidthardt, T.; Frohn, C.; Luhm, J.; Kirchner, H.; Brand, J.M. Prolactin induces enhanced interferon gamma release in peripheral whole blood after stimulation with either PHA or LPS. Immunobiology, 2002, 206, 424-431.
79. Guzmán, E.A.; Chen, Y.H.; Langowski, J.L.; De Guzman, A.; Lo, H.L.; Walter, B.; Muller, H.K.; Walker, A.M.; Owen, L.B. Abrogation of delayed type hypersensitivity response to Candida albicans produced by a molecular mimic of phosphorylated prolactin. J. Neuroimmunol., 2005, 170, 31-40.
80. Auchtung, T.L.; Dahl, G.E. Prolactin mediates photoperiodic immune enhancement: effects of administration of exogenous prolactin on circulating concentrations, receptor expression, and immune function in steers. Biol. Reprod., 2004, 71, 1913-1918.
81. Urtishak, S.L.; McKenna, E.A.; Mastro, A.M. Prolactin and prolactin receptor expression in rat, small intestine, intraepithelial lymphocytes during neonatal development. Dev. Immunol., 2001, 8, 319-330
82. Walker, A.M. Unmodified and phosphorylated prolactin and gamma delta T cell development and function. Lupus, 2001, 10, 735-741
83. Dohi, K.; Kraemer, W.J.; Mastro, A.M. Exercise increases prolactin-receptor expression on human lymphocytes. J. Appl. Physiol., 2003, 94, 518-524.
84. Brand, J.M.; Schmucker, P.; Breidthardt, T.; Kirchner, H. Upregulation of IFN-gamma and soluble interleukin-2 receptor release and altered serum cortisol and prolactin concentration during general anesthesia. J. Interferon Cytokine Res., 2001, 21, 793-796.
85. Dimitrov, S.; Lange, T.; Fehm, H.L.; Born, J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav. Immun., 2004, 18, 368-374.
86. Zhang, W.C.; Sun, R.; Zhang, J.; Zhang, J.; Tian, Z. Recombinant human prolactin protects against irradiation-induced myelosuppression. Cell. Mol. Immunol., 2005, 2, 379-385.
87. Sun, R.; Zhang, J.; Zhang, C.; Zhang, J.; Liang, S.; Sun, A.; Wang, J.; Tian, Z. Human prolactin improves engraftment and reconstitution of human peripheral blood lymphocytes in SCID mice. Cell. Mol. Immunol., 2004, 1, 129-136.
88. Sun, R.; Gault, R.A.; Welniak, L.A.; Tian, Z.G.; Richards, S.; Murphy, W.J. Immunologic and hematopoietic effects of recombinant human prolactin after syngeneic bone marrow transplantation in mice. Biol. Blood Marrow Transplant., 2003, 9, 426-434.
89. Gilleran, J.P.; Putz, O.; DeJong, M.; DeJong, S.; Birch, L.; Pu, Y.; Huang, L.; Prins, G.S. The role of prolactin in the prostatic inflammatory response to neonatal estrogen. Endocrinology, 2003, 144, 2046-2054
90. Kadioglu, P.; Acbay, O.; Demir, G.; Gazioglu, N.; Gundogdu, S. The effect of prolactin and bromocriptine on human peripheral immune status. J. Endocrinol. Invest., 2001, 24, 147-151.
91. Oberbeck, R.; Schmitz, D.; Wilsenack, K.; Schüler, M.; Pehle, B.; Schedlowski, M.; Exton, M.S. Metoclopramide and cellular immune functions during polymicrobial sepsis. Eur. Surg. Res., 2004, 36, 116-122.
92. Diaz, L.E.; Cano, P.; Jimenez-Ortega, V.; Nova, E.; Romeo, J.; Marcos, A.; Esquifino, A.I. Effects of moderate consumption of distilled and fermented alcohol on some aspects of neuroimmuno-modulation. Neuroimmunomodulation, 2007, 14, 200-205.
93. Ko, J.Y.; Ahn, Y.L.; Cho, B.N. Angiogenesis and white blood cell proliferation induced in mice by injection of a prolactin expressing plasmid into muscle. Mol. Cells, 2003, 15, 262-270.
94. Koehler, K.F.; Helguero, L.A.; Haldosén, L.A.; Warner, M.; Gustafsson, J.A. Reflections on the discovery and significance of estrogen receptor beta. Endocr. Rev., 2005, 26, 465-478.
95. Curtis Hewitt, S.; Couse, J.F.; Korach, K.S. Estrogen receptor transcription and transactivation: Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action. Breast Cancer Res., 2000, 2, 345-352.
96. Kalaitzidis, D.; Gilmore, T.D. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol. Metab., 2005, 16, 46-52.
97. Murphy, A.J.; Guyre, P.M.; Wira, C.R.; Pioli, P.A. Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. PLoS One, 2009, 4, e5539.
98. Scariano, J.K.; Emery-Cohen, A.J.; Pickett, G.G.; Morgan, M.; Simons, P.C.; Alba, F. Estrogen receptors alpha (ESR1) and beta (ESR2) are expressed in circulating human lymphocytes. J. Recept. Signal Trans. Res., 2008, 28, 285-293.
99. Subramanian, M.; Shaha, C. Estrogen modulates human macrophage apoptosis via differential signaling through estrogen receptor-alpha and beta. J. Cell Mol. Med., 2009, 13(8B), 2317-2329.
100. Watson, C.S.; Gametchu, B. Membrane estrogen and glucocorticoid receptors--implications for hormonal control of immune function and autoimmunity. Int. Immunopharmacol., 2001, 1, 1049-1063.
101. Lambert, K.C.; Curran, E.M.; Judy, B.M.; Lubahn, D.B.; Estes, D.M. Estrogen receptor-alpha deficiency promotes increased TNF-alpha secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro. J. Leukoc. Biol., 2004, 75, 1166-1172.
102. Benten, W.P.; Stephan, C.; Wunderlich, F. B cells express intracellular but not surface receptors for testosterone and estradiol. Steroids, 2002, 67, 647-654.
103. Curran, E.M.; Berghaus, L.J.; Vernetti, N.J.; Saporita, A.J.; Lubahn, D.B.; Estes, D.M. Natural killer cells express estrogen receptor-alpha and estrogen receptor-beta and can respond to estrogen via a non-estrogen receptor-alpha-mediated pathway. Cell. Immunol., 2001, 214, 12-20.
104. Phiel, K.L.; Henderson, R.A.; Adelman, S.J.; Elloso, M.M. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol. Lett., 2005, 97, 107-113.
105. Lamote, I.; Meyer, E.; De Ketelaere, A.; Duchateau, L.; Burvenich, C. Expression of the estrogen receptor in blood neutrophils of dairy cows during the periparturient period. Theriogenology, 2006, 65, 1082-1098.
106. Douin-Echinard, V.; Laffont, S.; Seillet, C.; Delpy, L.; Krust, A.; Chambon, P.; Gourdy, P.; Arnal, J.F.; Guéry, J.C. Estrogen receptor alpha, but not beta, is required for optimal dendritic cell differentiation and [corrected] CD40-induced cytokine production. J. Immunol., 2008, 180, 3661-3669.
107. Sierra, A.; Gottfried-Blackmore, A.; Milner, T.A.; McEwen, B.S.; Bulloch, K. Steroid hormone receptor expression and function in microglia. Glia, 2008, 56, 659-674.
108. Refojo, D.; Liberman, A.C.; Giacomini, D.; Carbia Nagashima, A.; Graciarena, M.; Echenique, C.; Paez Pereda, M.; Stalla, G.; Holsboer, F.; Arzt, E. Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells. Ann. N. Y. Acad. Sci., 2003, 992, 196-204.
109. Kawana, K.; Kawana, Y.; Schust, D.J. Female steroid hormones use signal transducers and activators of transcription protein-mediated pathways to modulate the expression of T-bet in epithelial cells: a mechanism for local immune regulation in the human reproductive tract. Mol. Endocrinol., 2005, 19, 2047-2059.
110. Dai, R.; Phillips, R.A.; Ahmed, S.A. Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3. J. Immunol., 2007, 179, 1776-1783.
111. Harris, H.A.; Albert, L.M.; Leathurby, Y.; Malamas, M.S.; Mewshaw, R.E.; Miller, C.; Kharode, Y.P.; Marzolf, J.; Komm, B.S.; Winneker, R.C.; Frail, D.E.; Henderson, R.A.; Zhu, Y.; Keith, J.C. Jr. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology, 2003, 144, 4241-4249.
112. Janele, D.; Lang, T.; Capellino, S.; Cutolo, M.; Da Silva, J.A.; Straub, R.H. Effects of testosterone, 17beta-estradiol, and down-stream estrogens on cytokine secretion from human leukocytes in the presence and absence of cortisol. Ann. N.Y. Acad. Sci., 2006, 1069, 168-182.
113. Mor, G.; Sapi, E.; Abrahams, V.M.; Rutherford, T.; Song, J.; Hao, X.Y.; Muzaffar, S.; Kohen, F. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J. Immunol., 2003, 170, 114-122.
114. McMurray, R.W.; Ndebele, K.; Hardy, K.J.; Jenkins, J.K. 17-beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine, 2001, 14, 324-333.
115. Karpuzoglu-Sahin, E.; Zhi-Jun, Y.; Lengi, A.; Sriranganathan, N.; Ansar Ahmed, S. Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice. Cytokine, 2001, 14, 208-217.
116. Maret, A.; Coudert, J.D.; Garidou, L.; Foucras, G.; Gourdy, P.; Krust, A.; Dupont, S.; Chambon, P.; Druet, P.; Bayard, F.; Guéry, J.C. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur. J. Immunol., 2003, 33, 512-521.
117. Islander, U.; Erlandsson, M.C.; Chavoshi, T.; Jochems, C.; Movérare, S.; Nilsson, S.; Ohlsson, C.; Gustafsson, J.A.; Carlsten, H. Estren-mediated inhibition of T lymphopoiesis is estrogen receptor-independent whereas its suppression of T cell-mediated inflammation is estrogen receptor-dependent. Clin. Exp. Immunol., 2005, 139, 210-215.
118. Islander, U.; Erlandsson, M.C.; Hasséus, B.; Jonsson, C.A.; Ohlsson, C.; Gustafsson, J.A.; Dahlgren, U.; Carlsten, H. Influence of oestrogen receptor alpha and beta on the immune system in aged female mice. Immunology, 2003, 110, 149-157.
119. Cho, J.L.; Allanson, M.; Domanski, D.; Arun, S.J.; Reeve, V.E. Estrogen receptor-beta signaling protects epidermal cytokine expression and immune function from UVB-induced impairment in mice. Photochem. Photobiol. Sci., 2008, 7, 120-125.
120. Piesta, A.; Maj, T.; Chelmońska-Soyta, A.The influence of mating on estrogen receptor alpha protein level in spleen and uterine macrophages in female mice. Reprod. Biol., 2009, 9, 225-240.
121. Guzmán, C.; Camacho-Arroyo, I.; De León-Nava, M.A.; Morales-Montor, J. Neonatal exposure to estradiol induces resistance to helminth infection and changes in the expression of sex steroid hormone receptors in the brain and spleen in adult mice of both sexes. Brain Behav. Immun., 2009, 23, 709-715.
122. Hilke, S.; Hökfelt, T.; Theodorsson, E. A short estrogen-responsive N-terminal galanin homologue found in rat brain and gut with antiserum raised against rat galanin(1-16). Neurochem. Res., 2006, 31, 177-188.
123. Jellinck, P.H.; Kaufmann, M.; Gottfried-Blackmore, A.; McEwen, B.S.; Jones, G.; Bulloch, K. Selective conversion by microglia of dehydroepiandrosterone to 5-androstenediol-A steroid with inherent estrogenic properties. J. Steroid Biochem. Mol. Biol., 2007, 107, 156-162.
124. Watanobe, H.; Yoneda, M. A mechanism underlying the sexually dimorphic ACTH response to lipopolysaccharide in rats: sex steroid modulation of cytokine binding sites in the hypothalamus. J. Physiol., 2003, 547, 221-232.
125. Mouihate, A.; Pittman, Q.J. Neuroimmune response to endogenous and exogenous pyrogens is differently modulated by sex steroids. Endocrinology, 2003, 144, 2454-2460.
126. Nordell, V.L.; Lewis, D.K.; Bake, S.; Sohrabji, F. The neurotrophin receptor p75NTR mediates early anti-inflammatory effects of estrogen in the forebrain of young adult rats. BMC Neurosci., 2005, 6, 58.
127. Beishuizen, A.; Thijs, L.G. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J. Endotoxin Res. 2003, 9, 3-24.
128. Tonelli, L.; Kramer, P.; Webster, J.I.; Wray, S.; Listwak, S.; Sternberg, E. Lipopolysaccharide-induced oestrogen receptor regulation in the paraventricular hypothalamic nucleus of lewis and Fischer rats. J. Neuroendocrinol., 2002, 14, 847-852.
129. Soucy, G.; Boivin, G.; Labrie, F.; Rivest, S. Estradiol is required for a proper immune response to bacterial and viral pathogens in the female brain. J. Immunol., 2005, 174, 6391-6398.
130. Kriegsfeld, L.J.; Hotchkiss, A.K.; Demas, G.E.; Silverman, A.J.; Silver, R.; Nelson, R.J. Brain mast cells are influenced by chemosensory cues associated with estrus induction in female prairie voles (Microtus ochrogaster). Horm. Behav., 2003, 44, 377-384.
131. Brown, C.M.; Choi, E.; Xu, Q.; Vitek, M.P.; Colton, C.A. The APOE4 genotype alters the response of microglia and macrophages to 17beta-estradiol. Neurobiol. Aging, 2008, 29, 1783-1794.
132. Dietrich, J.B. Endothelial cells of the blood-brain barrier: a target for glucocorticoids and estrogens? Front. Biosci., 2004, 9, 684-693.
133. Zhang, X.; Wang, L.; Dou, Y.; Zhao, J.; Jiang, T.; Qiao, Z.; Qiao, J. Testosterone and estradiol modulate TNF-alpha-induced expression of adhesion molecules in endothelial cells. Methods Find. Exp. Clin. Pharmacol., 2002, 24, 125-130.
134. Erlandsson, M.C.; Ohlsson, C.; Gustafsson, J.A.; Carlsten, H. Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology, 2001, 103, 17-25.
135. Lang, T.J. Estrogen as an immunomodulator. Clin. Immunol., 2004, 113, 224-230.
136. Gottfried-Blackmore, A.; Sierra, A.; Jellinck, P.H.; McEwen, B.S.; Bulloch, K. Brain microglia express steroid-converting enzymes in the mouse. J. Steroid. Biochem. Mol. Biol., 2008, 109, 96-107.
137. Stefano, G.B.; Peter, D. Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation: therapeutic implications. Med. Sci. Monit., 2001, 7, 1066-1074.
138. Li, X.; Xu, Y.; Ma, L.; Sun, L.; Fu, G.; Hou, Y. 17beta-estradiol enhances the response of plasmacytoid dendritic cell to CpG. PLoS One, 2009, 4, e8412.
139. Kyurkchiev, D.; Ivanova-Todorova, E.; Hayrabedyan, S.; Altankova, I.; Kyurkchiev, S. Female sex steroid hormones modify some regulatory properties of monocyte-derived dendritic cells. Am. J. Reprod. Immunol., 2007, 58, 425-433.
140. Karpuzoglu, E.; Fenaux, J.B.; Phillips, R.A.; Lengi, A.J.; Elvinger, F.; Ansar Ahmed, S. Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: role of interferon-gamma. Endocrinology, 2006, 147, 662-671.
141. Lagerquist, M.K.; Erlandsson, M.C.; Islander, U.; Svensson, L.; Holmdahl, R.; Carlsten, H. 17Beta-estradiol expands IgA-producing B cells in mice deficient for the mu chain. Scand. J. Immunol., 2008, 67, 12-17.
142. Hao, S.; Zhao, J.; Zhou, J.; Zhao, S.; Hu, Y.; Hou, Y. Modulation of 17beta-estradiol on the number and cytotoxicity of NK cells in vivo related to MCM and activating receptors. Int. Immunopharmacol., 2007, 7, 1765-1775.
143. Vlotides, G.; Gaertner, R.; Angstwurm, M.W. Modulation of monocytic lipopolysaccharide-induced tissue factor expression and tumor necrosis factor alpha release by estrogen and calcitriol. Hormones (Athens), 2007, 6, 52-61.
144. Pioli, P.A.; Jensen, A.L.; Weaver, L.K.; Amiel, E.; Shen, Z.; Shen, L.; Wira, C.R.; Guyre, P.M. Estradiol attenuates lipopolysaccharide-induced CXC chemokine ligand 8 production by human peripheral blood monocytes. J. Immunol., 2007, 179, 6284-6290.
145. Polanczyk, M.J.; Carson, B.D.; Subramanian, S.; Afentoulis, M.; Vandenbark, A.A.; Ziegler, S.F.; Offner, H. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J. Immunol., 2004, 173, 2227-2230.
146. Zang, Y.C.; Halder, J.B.; Hong, J.; Rivera, V.M.; Zhang, J.Z. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J. Neuroimmunol., 2002, 124, 106-114.
147. Lengi, A.J.; Phillips, R.A.; Karpuzoglu, E.; Ahmed, S,A. 17beta-estradiol downregulates interferon regulatory factor-1 in murine splenocytes. J. Mol. Endocrinol., 2006, 37, 421-432.
148. Berghöfer, B.; Frommer, T.; Haley, G.; Fink, L.; Bein, G.; Hackstein, H. TLR7 ligands induce higher IFN-alpha production in females. J. Immunol., 2006, 177, 2088-2096.
149. Dai, R.; Phillips, R.A.; Zhang, Y.; Khan, D.; Crasta, O.; Ahmed, S.A.Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microR-NAs: a novel mechanism of immune modulation. Blood, 2008, 112, 4591-4597.
150. Karpuzoglu-Sahin, E.; Hissong, B.D.; Ansar Ahmed, S. Interferon-gamma levels are upregulated by 17-beta-estradiol and diethylstil-bestrol. J. Reprod. Immunol., 2001, 52, 113-127.
151. Percegoni, N.; Ferreira, A.C.; Rodrigues, C.F.; Rosenthal, D.; Castelo Branco, M.T.; Rumjanek, V.M.; Carvalho, D.P. Profile of serum IL-1beta and IL-10 shortly after ovariectomy and estradiol replacement in rats. Horm. Metab. Res., 2009, 41, 50-54.
152. Canellada, A.; Alvarez, I.; Berod, L.; Gentile, T. Estrogen and progesterone regulate the IL-6 signal transduction pathway in antibody secreting cells. J. Steroid. Biochem. Mol. Biol., 2008, 111, 255-261.
153. Bengtsson, A.K.; Ryan, E.J.; Giordano, D.; Magaletti, D.M.; Clark, E.A. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood, 2004, 104, 1404-1410.
154. Sakazaki, H.; Ueno, H.; Nakamuro, K. Estrogen receptor alpha in mouse splenic lymphocytes: possible involvement in immunity. Toxicol. Lett., 2002, 133(2-3), 221-229.
155. Arlt, W.; Hewison, M. Hormones and immune function: implications of aging. Aging Cell, 2004, 3, 209-216.
156. Salem, M.L. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr. Drug Targets Inflamm. Allergy, 2004, 3, 97-104.
157. Beagley, K.W.; Gockel, C.M. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol. Med. Microbiol., 2003, 38, 13-22.
158. Li, J.; McMurray, R.W. Effects of Cyclic Versus Sustained Estrogen Administration on Peripheral Immune Functions in Ovariectomized Mice. Am. J. Reprod. Immunol., 2010, 63, 274-281.
159. Karpuzoglu-Sahin, E.; Gogal, R.M. Jr.; Hardy, C.; Sponenberg, P.; Ahmed, S.A. Short-term administration of 17-beta estradiol to outbred male CD-1 mice induces changes in the immune system, but not in reproductive organs. Immunol. Invest., 2005, 34, 1-26.
160. Bouman, A.; Heineman, M.J.; Faas, M.M. Sex hormones and the immune response in humans. Hum. Reprod. Update, 2005, 11, 411-423.
161. Colton, C.A.; Brown, C.M.; Vitek, M.P. Sex steroids, APOE geno-type and the innate immune system. Neurobiol. Aging, 2005, 26, 363-372.
162. Kovats, S.; Carreras, E. Regulation of dendritic cell differentiation and function by estrogen receptor ligands. Cell. Immunol., 2008, 252, 81-90.
163. Pauklin, S.; Sernández, I.V.; Bachmann, G.; Ramiro, A.R.; Petersen-Mahrt, S.K. Estrogen directly activates AID transcription and function. J. Exp. Med., 2009, 206, 99-111.
164. Li, J.; McMurray, R.W. Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice. Int. Immunopharmacol., 2006, 6, 1413-1423.
165. Karpuzoglu, E.; Ahmed, S.A. Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis. Nitric Oxide, 2006, 15, 177-186.
166. Tai, P.; Wang, J.; Jin, H.; Song, X.; Yan, J.; Kang, Y.; Zhao, L.; An, X.; Du, X.; Chen, X.; Wang, S.; Xia, G.; Wang, B. Induction of regulatory T cells by physiological levels of estrogen. J. Cell. Physiol., 2008, 214, 456-464.
167. Hirano, S.; Furutama, D.; Hanafusa, T. Physiologically high concentrations of 17beta-estradiol enhance NF-kappaB activity in human T cells. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 292, R1465-1471.
168. Prieto, G.A.; Rosenstein, Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology, 2006, 118, 58-65.
169. Zajchowski, S.; Hoffman-Goetz, L. Supraphysiological level of estrogen exposure in vivo increases lymphoid cell death in mice. Life Sci., 2000, 66, 1451-1459.
170. Mao, A.; Paharkova-Vatchkova, V.; Hardy, J.; Miller M.M.; Kovats, S. Estrogen selectively promotes the differentiation of dendritic cells with characteristics of Langerhans cells. J. Immunol., 2005, 175, 5146-5151.
171. Zhang, Q.H.; Cao, J.; Hu, Y.Z.; Huang, Y.H.; Lü, S.Y.; Wei, G.Z.; Zhao, Y.F. Morphological observation of immunological alterations in the spleens from estrogen receptor deficient mice. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2004, 20, 1-6.
172. Yang, L.; Liang, J.; Yao, G.; Chen, P.; Hou, Y. 17beta-estradiol regulates the numbers, endocytosis, stimulative capacity and IL-10 secretion of mouse spleen dendritic cells. Toxicol. Lett., 2005, 155, 239-246.
173. Yang, L.; Hu, Y.; Hou, Y. Effects of 17beta-estradiol on the maturation, nuclear factor kappa B p65 and functions of murine spleen CD11c-positive dendritic cells. Mol. Immunol., 2006, 43, 357-366.
174. Xiao, B.G.; Liu, X.; Link, H. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis. Steroids, 2004, 69, 653-659.
175. Cutolo, M.; Capellino, S.; Montagna, P.; Ghiorzo, P.; Sulli, A.; Villaggio, B. Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line. Arthritis Res. Ther. 2005, 7, R1124-1132.
176. Cutolo, M.; Villaggio, B.; Bisso, A.; Sulli, A.; Coviello, D.; Dayer, J.M. Presence of estrogen receptors in human myeloid monocytic cells (THP-1 cell line). Eur. Cytokine Netw., 2001, 12, 368-372.
177. Gomez, F.; Ruiz, P.; Bernal, J.A.; Escobar, M.; Garcia-Egido, A.; Lopez-Saez, J.J. Enhancement of splenic-macrophage Fcgamma receptor expression by treatment with estrogens. Clin. Diagn. Lab. Immunol., 2001, 8, 806-8010.
178. Gourdy, P.; Araujo, L.M.; Zhu, R.; Garmy-Susini, B.; Diem, S.; Laurell, H.; Leite-de-Moraes, M.; Dy, M.; Arnal, J.F.; Bayard, F.; Herbelin, A. Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-gamma production by invariant natural killer T cells. Blood, 2005, 105, 2415-2420.
179. Murphy, H.S.; Sun, Q.; Murphy, B.A.; Mo, R.; Huo, J.; Chen, J.; Chensue, S.W.; Adams, M.; Richardson B.C.; Yung, R. Tissue-specific effect of estradiol on endothelial cell-dependent lymphocyte recruitment. Microvasc. Res., 2004, 68(3), 273-285.
180. Zhang, X.; Wang, L.Y.; Jiang, T.Y.; Zhang, H.P.; Dou, Y.; Zhao, J.H.; Zhao, H.; Qiao, Z.D.; Qiao, J.T. Effects of testosterone and 17-beta-estradiol on TNF-alpha-induced E-selectin and VCAM-1 expression in endothelial cells. Analysis of the underlying receptor pathways. Life Sci., 2002, 71, 15-29.
181. Stygar, D.; Masironi, B.; Eriksson, H.; Sahlin, L. Studies on estrogen receptor (ER) alpha and beta responses on gene regulation in peripheral blood leukocytes in vivo using selective ER agonists. J. Endocrinol., 2007, 194, 101-119.
182. Quinn, M.J. Jr.; McKernan, M.; Lavoie, E.T.; Ottinger, M.A. Effects of estradiol on the development of the bursa of Fabricius in Japanese quail. J. Exp. Zool. A. Ecol. Genet. Physiol., 2009, 311, 91-95.
183. Lü, F.X.; Abel, K.; Ma, Z.; Rourke, T.; Lu, D.; Torten, J.; McChesney, M.; Miller, C.J. The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones. Clin. Exp. Immunol., 2002, 128, 10-20.
184. Moxley, G.; Posthuma, D.; Carlson, P.; Estrada, E.; Han, J.; Benson, L.L.; Neale, M.C. Sexual dimorphism in innate immunity. Arthritis Rheum., 2002, 46(1), 250-258
185. Macciò, A.; Madeddu, C.; Sanna, E.; Panzone, F.; Volpe, A.; Mantovani, G. Evidence that human serum with high levels of estrogens interferes with immune system both by decreasing CD25 expression on T-cell and by increasing interleukin-2 availability. Reprod. Sci., 2008, 15, 961-969.
186. McMurray, R.W.; Suwannaroj, S.; Ndebele, K.; Jenkins, J.K. Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels. Pathobiology, 2001, 69, 44-58.
187. Nakaya, M.; Yamasaki, M.; Tachibana, H.; Yamada, K. IgM production of lymphocytes from C57BL/6N mice was stimulated by estrogen treated splenic adherent cells. Immunol. Lett., 2005, 98, 225-231.
188. Grimaldi, C.M.; Cleary, J.; Dagtas, A.S.; Moussai, D.; Diamond, B. Estrogen alters thresholds for B cell apoptosis and activation. J. Clin. Invest., 2002, 109, 1625-1633.
189. Matejuk, A.; Bakke, A.C.; Hopke, C.; Dwyer, J.; Vandenbark, A.A.; Offner, H. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. J. Neurosci. Res., 2004, 77, 119-126.
190. Adamski, J.; Benveniste, E.N. 17beta-estradiol activation of the c-Jun N-terminal kinase pathway leads to down-regulation of class II major histocompatibility complex expression. Mol. Endocrinol., 2005, 19, 113-124.
191. Lambert, K.C.; Curran, E.M.; Judy, B.M.; Milligan, G.N.; Lubahn, D.B.; Estes, D.M. Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation. J. Immunol., 2005, 175, 5716-5723.
192. Zhang, Q.H.; Hu, Y.Z.; Cao, J.; Zhong, Y.Q.; Zhao, Y.F.; Mei, Q.B. Estrogen influences the differentiation, maturation and function of dendritic cells in rats with experimental autoimmune encephalomyelitis. Acta Pharmacol. Sin., 2004, 25, 508-513.
193. Rettew, J.A.; Huet, Y.M.; Marriott, I. Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo. Endocrinology, 2009, 150, 3877-3884.
194. Ding, J.; Zhu, B.T. Unique effect of the pregnancy hormone estriol on antigen-induced production of specific antibodies in female BALB/c mice. Steroids, 2008, 73, 289-298.
195. Thongngarm, T.; Jenkins, J.K.; Ndebele, K.; McMurray, R.W. Estrogen and progesterone modulate monocyte cell cycle progression and apoptosis. Am. J. Reprod. Immunol., 2003, 49, 129-138.
196. Islander, U.; Hasséus, B.; Erlandsson, M.C.; Jochems, C.; Skrtic, S.M.; Lindberg, M.; Gustafsson, J.A.; Ohlsson, C.; Carlsten, H. Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands. B.M.C. Immunol., 2005, 6, 16.
197. Weitzmann, M.N.; Pacifici, R. Role of the immune system in postmenopausal bone loss. Curr. Osteoporos. Rep., 2005, 3, 92-97.
198. Weitzmann, M.N.; Pacifici, R. Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Invest., 2006, 116, 1186-1194.
199. Weitzmann, M.N.; Pacifici, R. T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis. Ann. N.Y. Acad. Sci., 2007, 1116, 360-375.
200. Pacifici, R. Estrogen deficiency, T cells and bone loss. Cell. Immunol., 2008, 252, 68-80.
201. Carlsten, H. Immune responses and bone loss: the estrogen connection. Immunol. Rev., 2005, 208, 194-206.
202. Martin, T.J.; Udagawa, N. Hormonal regulation of osteoclast function. Trends Endocrinol. Metab., 1998, 9, 6-12.
203. García-Pérez, M.A.; Noguera, I.; Hermenegildo, C.; Martínez-Romero, A.; Tarín, J.J.; Cano, A. Alterations in the phenotype and function of immune cells in ovariectomy-induced osteopenic mice. Hum. Reprod., 2006, 21, 880-887.
204. Ryan, M.R.; Shepherd, R.; Leavey, J.K.; Gao, Y.; Grassi, F.; Schnell, F.J.; Qian, W.P.; Kersh, G.J.; Weitzmann, M.N.; Pacifici, R. An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc. Natl. Acad. Sci. USA, 2005, 102, 16735-16740.
205. Roggia, C.; Tamone, C.; Cenci, S.; Pacifici, R.; Isaia, G.C. Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency Minerva Med., 2004, 95, 125-132.
206. Cenci, S.; Toraldo, G.; Weitzmann, M.N.; Roggia, C.; Gao, Y.; Qian, W.P.; Sierra, O.; Pacifici, R. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc. Natl. Acad. Sci. USA, 2003, 100, 10405-10410.
207. Carreras, E.; Turner, S.; Paharkova-Vatchkova, V.; Mao, A.; Dascher, C.; Kovats, S. Estradiol acts directly on bone marrow myeloid progenitors to differentially regulate GM-CSF or Flt3 ligand-mediated dendritic cell differentiation. J. Immunol., 2008, 180, 727-738.
208. Kayisli, U.A.; Guzeloglu-Kayisli, O.; Arici, A. Endocrine-immune interactions in human endometrium. Ann. N.Y. Acad. Sci., 2004, 1034, 50-63.
209. Gellersen, B.; Brosens, I.A.; Brosens, J.J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin. Reprod. Med., 2007, 25, 445-453.
210. Roberts, M.; Luo, X.; Chegini, N. Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-alpha and TGF-beta in human endometrial epithelial and stromal cells. Mol. Hum. Reprod., 2005, 11, 751-760.
211. Schaefer, T.M.; Wright, J.A.; Pioli, P.A.; Wira, C.R. IL-1beta-mediated proinflammatory responses are inhibited by estradiol via down-regulation of IL-1 receptor type I in uterine epithelial cells. J. Immunol., 2005, 175, 6509-6516.
212. Rhen, T.; Cidlowski, J.A. Estrogens and glucocorticoids have opposing effects on the amount and latent activity of complement proteins in the rat uterus. Biol. Reprod., 2006, 74, 265-274.
213. Dong, M.; Ding, G.; Zhou, J.; Wang, H.; Zhao, Y.; Huang, H. The effect of trophoblasts on T lymphocytes: possible regulatory effector molecules--a proteomic analysis. Cell. Physiol. Biochem., 2008, 21, 463-472.
214. Akoum, A.; Metz, C.N.; Morin, M. Marked increase in macrophage migration inhibitory factor synthesis and secretion in human endometrial cells in response to human chorionic gonadotropin hormone. J. Clin. Endocrinol. Metab., 2005, 90, 2904-2910.
215. Shimada, M.; Hernandez-Gonzalez, I.; Gonzalez-Robanya, I.; Richards, J.S. Induced expression of pattern recognition receptors in cumulus oocyte complexes: novel evidence for innate immune-like functions during ovulation. Mol. Endocrinol., 2006, 12, 3228-3239.
216. Altuntas, C.Z.; Johnson, J.M.; Tuohy, V.K. Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure. J. Immunol., 2006, 177, 1988-1996.
217. Kendall, N.R.; Gutierrez, C.G.; Scaramuzzi, R.J.; Baird, D.T.; Webb, R.; Campbell, B.K. Direct in vivo effects of leptin on ovarian steroidogenesis in sheep. Reproduction, 2004, 128, 757-765.
218. Bouman, A.; Moes, H.; Heineman, M.J.; de Leij, L.F.; Faas, M.M. The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin. Fertil. Steril., 2001, 76, 555-559.
219. Valenti. S.; Giusti, M. Melatonin participates in the control of testosterone secretion from rat testis: an overview of our experience. Ann. N.Y. Acad. Sci, 2002, 966, 284-289.
220. Doria, A.; Iaccarino, L.; Sarzi-Puttini, P.; Ghirardello, A.; Zampieri, S.; Arienti, S.; Cutolo, M.; Todesco, S. Estrogens in pregnancy and systemic lupus erythematosus. Ann. N.Y. Acad. Sci, 2006, 1069, 247-256.
221. Doria, A.; Iaccarino, L.; Arienti, S.; Ghirardello, A.; Zampieri, S.; Rampudda, M.E.; Cutolo, M.; Tincani, A.; Todesco, S. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod. Toxicol., 2006, 22, 234-241.
222. Seavey, M.M.; Mosmann, T.R. Paternal antigen-bearing cells transferred during insemination do not stimulate anti-paternal CD8+ T cells: role of estradiol in locally inhibiting CD8+ T cell responses. J. Immunol., 2006, 177, 7567-7578.
223. Chantakru, S.; Wang, W.C.; van den Heuvel, M.; Bashar, S.; Simpson, A.; Chen, Q.; Croy, B.A.; Evans, S.S. Coordinate regulation of lymphocyte-endothelial interactions by pregnancy-associated hormones. J. Immunol., 2003, 171, 4011-4019.
224. Hoffman-Goetz, L.; Fietsch, C.L.; McCutcheon, D.; Duerrstein, L. Effect of 17beta-estradiol and voluntary exercise on lymphocyte apoptosis in mice. Physiol. Behav., 2001, 74, 653-658.
225. Johnson, A.B.; Sohrabji, F. Estrogen's effects on central and circulating immune cells vary with reproductive age. Neurobiol. Aging., 2005, 26, 1365-1374.
226. Igarashi, H.; Kouro, T.; Yokota, T.; Comp, P.C.; Kincade, P.W. Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc. Natl. Acad. Sci. USA, 2001, 98, 15131-15136.
227. Khorram, O.; Garthwaite, M.; Golos, T. The influence of aging and sex hormones on expression of growth hormone-releasing hormone in the human immune system. J. Clin. Endocrinol. Metab., 2001, 86, 3157-3161.
228. Gomez, C.R.; Plackett, T.P.; Kovacs, E.J. Aging and estrogen: modulation of inflammatory responses after injury. Exp. Gerontol., 2007, 42, 451-456.
229. Kovacs, E.J.; Duffner, L.A.; Plackett, T.P. Immunosuppression after injury in aged mice is associated with a TH1-TH2 shift, which can be restored by estrogen treatment. Mech. Ageing Dev., 2004, 125, 121-123.
230. Cvoro, A.; Tatomer, D.; Tee, M.K.; Zogovic, T.; Harris, H.A.; Leitman, D.C. Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes. J. Immunol. 2008; 180, 630-636.
231. Tiwari-Woodruff, S.; Voskuhl, R.R. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. J. Neurol. Sci., 2009, 286, 81-85.
232. Schild-Hay, L.J.; Leil, T.A.; Divi, R.L.; Olivero, O.A.; Weston, A.; Poirier, M.C. Tamoxifen induces expression of immune response related genes in cultured normal human mammary epithelial cells. Cancer Res., 2009, 69, 1150-1155.
233. Behjati, S.; Frank, M.H. The effects of tamoxifen on immunity. Curr. Med. Chem., 2009, 16, 3076-3080.
234. Vargas-Villavicencio, J.A.; Larralde, C.; De León-Nava, M.A.; Escobedo, G.; Morales-Montor, J. Tamoxifen treatment induces protection in murine cysticercosis. J. Parasitol., 2007, 93, 1512-1517.
235. Nalbandian, G.; Paharkova-Vatchkova, V.; Mao, A.; Nale, S.; Kovats, S. The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation. J. Immunol., 2005, 175, 2666-2675.
236. Erlandsson, M.C.; Jonsson, C.A.; Lindberg, M.K.; Ohlsson, C.; Carlsten, H. Raloxifene- and estradiol-mediated effects on uterus, bone and B lymphocytes in mice. J. Endocrinol., 2002, 175, 319-327.
237. Kumru, S.; Yildiz, F.M.; Godekmerdan, A.; Kutlu, S.; Yilmaz, B.; Gurates, B. Effects of raloxifene and hormone replacement therapy on serum Th2 and Th3 type cytokine concentrations in healthy postmenopausal women: a randomised controlled trial. Arch. Gynecol. Obstet., 2008, 277, 489.
238. Engdahl, C.; Jochems, C.; Gustafsson, J.A.; van der Saag, P.T.; Carlsten, H.; Lagerquist, M.K. In vivo activation of gene transcription via oestrogen response elements by a raloxifene analogue. J. Endocrinol., 2009, 203, 349-356.
239. Dhaher, Y.Y.; Greenstein, B.D.; Khamashta, M.A.; Hughes, G.R. Effects of oestradiol and the oestrogen antagonist Ici 182,780 on the delayed type hypersensitivity (DTH) index and on serum levels of IgM and IgG in ovariectomised Balb/C and MRL/Mp-Lpr/Lpr mice, a model of systemic lupus erythematosus (SLE). Autoimmunity, 2001, 33, 237-243.
240. Hernandez-Segura, A.M.; Ayala-Garcia, I.; Alvarez-Pérez, S.J.; Castell-Rodriguez, A.E.; Hernandez-Tellez, B.; Mandoki, J.J.; Ramirez-Gonzalez, M.D. Effects of single administration of diethyl-stilbestrol on murine langerhans cells. Proc. West. Pharmacol. Soc., 2005, 48, 129-133.
241. Brown, N.; Nagarkatti, M.; Nagarkatti, P.S. Diethylstilbestrol alters positive and negative selection of T cells in the thymus and modulates T-cell repertoire in the periphery. Toxicol. Appl. Pharmacol., 2006, 212, 119-126.
242. Burke, L.; Segall-Blank, M.; Lorenzo, C.; Dynesius-Trentham, R.; Trentham, D.; Mortola, J.F. Altered immune response in adult women exposed to diethylstilbestrol in utero. Am. J. Obstet. Gynecol., 2001, 185, 78-81.
243. Utsuyama, M.; Kanno, J.; Inoue, T.; Hirokawa, K. Age/sex dependent and non-monotonous dose-response effect of diethylstilbestrol on the immune functions in mice. Toxicol. Lett., 2002, 135, 145-153.
244. Janssen, G.B.; Penninks, A.H.; Knippels, L.M.; van Zijverden, M.; Spanhaak, S. The evaluation of the immunomodulating properties of ERA-63 a pharmaceutical with estrogenic activity. Toxicol. Lett., 2008, 180, 196-201.
245. Coelingh Bennink, H.J.; Holinka, C.F.; Diczfalusy, E. Estetrol review: profile and potential clinical applications. Climacteric, 2008, 11 (Suppl. 1), 47-58.
246. Kasperska-Zajac, A.E.; Brzoza, Z.K.; Koczy-Baron, E.; Jagodzinska, J. Dehydroepiandrosterone in therapy of allergic diseases. Recent Pat. Inflamm. Allergy Drug Discov., 2009, 3, 211-213
247. Cutolo, M.; Straub, R.H.; Bijlsma, J.W. Neuroendocrine-immune interactions in synovitis. Nat. Clin. Pract. Rheumatol., 2007, 3, 627-634.
248. Owen-Ashley, N.T.; Hasselquist, D.; Wingfield, J.C. Androgens and the immunocompetence handicap hypothesis: unraveling direct and indirect pathways of immunosuppression in song sparrows. Am. Nat., 2004, 164, 490-505.
249. Loria, R.M. Immune up-regulation and tumor apoptosis by androstene steroids. Steroids, 2002, 67, 953-966.
250. Brown, C.M.; Xu, Q.; Okhubo, N.; Vitek, M.P.; Colton, C.A. Androgen-mediated immune function is altered by the apolipoprotein E gene. Endocrinology, 2007, 148, 3383-3390
251. Namazi, M.R. The Th1-promoting effects of dehydroepiandroster-one can provide an explanation for the stronger Th1-immune response of women. Iran J. Allergy Asthma Immunol., 2009, 8, 65-69.
252. Ahmadi, K.; McCruden, A.B. Macrophage may responses to androgen via its receptor. Med. Sci. Monit., 2006, 12, BR15-20.
253. Olsen, N.J.; Kovacs, W.J. Effects of androgens on T and B lymphocyte development. Immunol. Res., 2001, 23, 281-288.
254. Sterzl, I.; Hampl, R.; Hill, M.; Hrdá, P.; Matucha, P. Immunomodulatory cytokines in human seminal plasma correlate with immunomodulatory steroids. Steroids, 2003, 68, 725-731.
255. Christodoulakos, G.E.; Lambrinoudaki, I.V.; Economou, E.V.; Papadias, C.; Vitoratos, N.; Panoulis, C.P.; Kouskouni, E.E.; Vlachou, S.A.; Creatsas, G.C. Circulating chemoattractants RAN-TES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene. Atherosclerosis, 2007, 193, 142-150.
256. Ahlem, C.; Auci, D.; Mangano, K.; Reading, C.; Frincke, J.; Stickney, D.; Nicoletti, F. HE3286: a novel synthetic steroid as an oral treatment for autoimmune disease. Ann. N.Y. Acad. Sci., 2009, 1173, 781-790.
257. Page, S.T.; Plymate, S.R.; Bremner, W.J.; Matsumoto, A.M.; Hess, D.L.; Lin, D.W.; Amory, J.K.; Nelson, P.S.; Wu, J.D. Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testoster-one and/or its metabolites. Am. J. Physiol. Endocrinol. Metab., 2006, 290, E856-863.
258. Le Bouteiller, P.; Piccinni, M.P. Human, NK cells in pregnant uterus: why there? Am. J. Reprod. Immunol., 2008, 59, 401-406.
259. Hughes, G.C.; Clark, E.A. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity, 2007, 40, 470-481.
260. Druckmann, R.; Druckmann, M.A. Progesterone and the immunology of pregnancy. J. Steroid. Biochem. Mol. Biol., 2005, 97, 389-396.
261. Lewis, G.S. Steroidal regulation of uterine immune defenses. Anim. Reprod. Sci., 2004, 82-83, 281-294.
262. Dosiou, C.; Hamilton, A.E.; Pang, Y.; Overgaard, M.T.; Tulac, S.; Dong, J.; Thomas, P.; Giudice, L.C. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J. Endocrinol., 2008, 196, 67-77.
263. Su, L.; Sun, Y.; Ma, F.; Lü, P.; Huang, H.; Zhou, J. Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression. Immunol. Lett., 2009, 125, 151-155.
264. Arruvito, L.; Giulianelli, S.; Flores, A.C.; Paladino, N.; Barboza, M.; Lanari, C.; Fainboim, L. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J. Immunol., 2008, 180, 5746-5753.
265. Schwartz, N.; Xue, X.; Elovitz, M.A.; Dowling, O.; Metz, C.N. Progesterone suppresses the fetal inflammatory response ex vivo. Am. J. Obstet. Gynecol., 2009, 201, 211-219.
266. Girón-González, J.A.; Moral, F.J.; Elvira, J.; García-Gil, D.; Guerrero, F.; Gavilán, I.; Escobar, L. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur. J. Endocrinol., 2000, 143(1), 31-36.
267. Müller, E.; Kerschbaum, H.H. Progesterone and its metabolites 5-dihydroprogesterone and 5-3-tetrahydroprogesterone decrease LPS-induced NO release in the murine microglial cell line, BV-2. Neuro Endocrinol. Lett., 2006, 27, 675-678.
268. Bazer, F.W.; Spencer, T.E.; Johnson, G.A. Interferons and uterine receptivity. Semin. Reprod. Med. 2009, 27, 90-102.
269. Amsterdam, A.; Keren-Tal, I.; Aharoni, D.; Dantes, A.; Land-Bracha, A.; Rimon, E.; Sasson, R.; Hirsh, L. Steroidogenesis and apoptosis in the mammalian ovary. Steroids, 2003, 68, 861-867.
270. Chao, T.C.; Chao, H.H.; Chen, M.F.; Greager, J.A.; Walter, R.J. Female sex hormones modulate the function of LPS-treated macrophages. Am. J. Reprod. Immunol. 2000, 44, 310-318.
271. Yellon, S.M.; Ebner, C.A.; Elovitz, M.A. Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth. Reprod. Sci., 2009, 16, 257-264.
272. Butts, C.L.; Shukair, S.A.; Duncan, K.M.; Bowers, E.; Horn, C.; Belyavskaya, E.; Tonelli, L.; Sternberg, E.M. Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int. Immunol. 2007, 19, 287-296.
273. Yang, L.; Li, X.; Zhao, J.; Hou, Y. Progesterone is involved in the maturation of murine spleen CD11c positive dendritic cells. Steroids, 2006, 71, 922-929.
274. Liang, J.; Sun, L.; Wang, Q.; Hou, Y. Progesterone regulates mouse dendritic cells differentiation and maturation. Int. Immuno--pharmacol., 2006, 6, 830-838.
275. Huck, B.; Steck, T.; Habersack, M.; Dietl, J.; Kämmerer, U. Pregnancy associated hormones modulate the cytokine production but not the phenotype of PBMC-derived human dendritic cells. Eur. J. Obstet. Gynecol. Reprod. Biol., 2005, 122, 85-94.
276. Ivanova, E.; Kyurkchiev, D.; Altankova, I.; Dimitrov, J.; Binakova, E.; Kyurkchiev, S. CD83 monocyte-derived dendritic cells are present in human decidua and progesterone induces their differentiation in vitro. Am. J. Reprod. Immunol., 2005, 53, 199-205.
277. Piccinni, M.P.; Scaletti, C.; Maggi, E.; Romagnani, S. Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy. J. Neuroimmunol., 2000, 109, 30-33.
278. Auerbach, L.; Hafner, T.; Huber, J.C.; Panzer, S. Influence of low-dose oral contraception on peripheral blood lymphocyte subsets at particular phases of the hormonal cycle. Fertil. Steril., 2002, 78(1), 83-89.
279. Canellada, A.; Blois, S.; Gentile, T.; Margni Idehu, R.A. In vitro modulation of protective antibody responses by estrogen, progesterone and interleukin-6. Am. J. Reprod. Immunol., 2002, 48, 334-343.
280. Verthelyi, D.; Klinman, D.M. Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo. Immunology, 2000, 100, 384-390.
281. Chen, H.; Wu, Z.; Li, J.; Chen, R.; Yu, Y.; Xu, L.; Shuai, J.; Tu, Y.T. Effect of progesterone on gonococci-induced apoptosis and respiratory burst of human polymorphonuclear leukocytes in vitro. Int. J. Dermatol., 2009, 48, 1011-1016.
282. Brunton, P.J.; McKay, A.J.; Ochedalski, T.; Piastowska, A.; Rebas, E.; Lachowicz, A.; Russell, J.A. Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone. J. Neurosci., 2009, 29, 6449-6460.
283. Ildgruben, A.K.; Sjöberg, I.M.; Hammarström, M.L. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium. Obstet. Gynecol., 2003, 102, 571-582.
284. Faas, M.; Bouman, A.; Moesa, H.; Heineman, M.J.; de Leij, L.; Schuiling, G. The immune response during the luteal phase of the ovarian cycle: a Th2-type response? Fertil. Steril., 2000, 74, 1008-1013.
285. Booth, E.A.; Lucchesi, B.R. Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion. Am. J. Physiol. Heart. Circ. Physiol., 2007, 293, H1408-H1415
286. Orsal, A.S.; Blois, S.; Labuz, D.; Peters, E.M.; Schaefer, M.; Arck, P.C. The progesterone derivative dydrogesterone down-regulates neurokinin 1 receptor expression on lymphocytes, induces a Th2 skew and exerts hypoalgesic effects in mice. J. Mol. Med., 2006, 84, 159-167.
287. Veleiro, A.S.; Pecci, A.; Monteserín, M.C.; Baggio, R.; Garland, M.T.; Lantos, C.P.; Burton, G. 6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity. J. Med. Chem. 2005, 48, 5675-5683.
288. King, A.E.; Morgan, K.; Sallenave, J.M.; Kelly, R.W. Differential regulation of secretory leukocyte protease inhibitor and elafin by progesterone. Biochem. Biophys. Res. Commun., 2003, 310, 594-599.
289. Cheon, Y.P.; Xu, X.; Bagchi, M.K.; Bagchi, I.C. Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse. Endocrinology, 2003, 144, 5623-5630.
290. Suzuki, T.; Murry, B.A.; Darnel, A.D.; Sasano, H. Progesterone metabolism in human leukemic monoblast U937 cells. Endocr. J., 2002, 49, 539-446.
291. Rugarn, O.; Hammar, M.; Theodorsson, E. Progesterone and nore-thisterone have different effects on tachykinin-like immunoreactivity in rat cortex and striatum. Regul. Pept., 2001, 101, 87-91.
292. Bagchi, I.C.; Li, Q.; Cheon, Y.P.; Mantena, S.R.; Kannan, A.; Bagchi, M.K. Use of the progesterone receptor antagonist RU 486 to identify novel progesterone receptor-regulated pathways in implantation. Semin. Reprod. Med., 2005, 23, 38-45.
293. Khan, N.A.; Khan, A.; Savelkoul, H.F.; Benner, R. Inhibition of septic shock in mice by an oligopeptide from the beta-chain of human chorionic gonadotrophin hormone. Hum. Immunol., 2002, 63, 1-7.
294. Khil, L.Y.; Jun, H.S.; Kwon, H.; Yoo, J.K.; Kim, S.; Notkins, A.L.; Yoon, J.W. Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. Diabetologia, 2007, 50, 2147-2155.
295. Ueno, A.; Cho, S.; Cheng, L.; Wang, J.; Hou, S.; Nakano, H.; Santamaria, P.; Yang, Y. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes. Diabetes, 2007, 56, 1686-1693.
296. Li, N.; Shigihara, T.; Tzioufas, A.G.; Notkins, A.L.; Yoon, J.W.; Jun, H.S. Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice. Arthritis Rheum., 2007, 56, 2211-2215.
297. Liu, M.L.; Xu, G.; Xue, S.R.; Zhong, X.C.; Chen, G.X.; Chen, Z.J. Plasma levels of Th1/Th2 type cytokine are associated with change of prolactin and GH/IGF-I in hemodialysis patients. Int. J. Artif. Organs, 2008, 31, 303-308.
298. Dugan, A.L.; Schwemberger, S.; Noel, G.J.; Babcock, G.; Ogle, C.K.; Buckley, D.J.; Horseman, N.D.; Gregerson, K.A. Stress and prolactin effects on bone marrow myeloid cells, serum chemokine and serum glucocorticoid levels in mice. Neuroimmunomodulation, 2007, 14, 287-296.
299. Fomicheva, E.E.; Nemirovich-Danchenko, E.A.; Korneva, E.A. Immunoprotective effects of prolactin during stress-induced immune dysfunction. Bull. Exp. Biol. Med., 2004, 137, 544-547.
300. Imrich, R. The role of neuroendocrine system in the pathogenesis of rheumatic diseases (minireview). Endocr. Regul., 2002, 36, 95-106.
301. Blanco-Favela, F.; Chavez-Rueda, K.; Leaños-Miranda, A. Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus. Lupus, 2001, 10, 757-561.
302. De Bellis, A.; Bizzarro, A.; Pivonello, R.; Lombardi, G.; Bellastella, A. Prolactin and autoimmunity. Pituitary, 2005, 8, 25-30.
303. Peeva, E.; Zouali, M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol. Lett., 2005, 101, 123-143.
304. Vera-Lastra, O.; Jara, L.J.; Espinoza, L.R. Prolactin and autoimmunity. Autoimmun. Rev., 2002, 1, 360-4.
305. Jara, L.J.; Benitez, G.; Medina, G. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun. Rev., 2008, 7, 251-255.
306. Stevens, A.; Ray, D.; Alansari, A.; Hajeer, A.; Thomson, W.; Donn, R.; Ollier, W.E.; Worthington, J.; Davis, J.R. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum., 2001, 44, 2358-2366.
307. Rastin, M.; Hatef, M.R.; Tabasi, N.; Sheikh, A.; Morad Abbasi, J.; Mahmoudi, M. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients. Iran J. Immunol., 2007, 4, 110-115.
308. Tsinzerling, N.; Pirskanen, R.; Matell, G.; Zhulev, N.M.; Chukhlovina, M.L.; Lefvert, A.K. Raised prolactin levels in myasthenia gravis: two case reports and a study of two patient populations. Acta Neurol. Scand., 2006, 114, 346-349.
309. Then Bergh, F.; Kümpfel, T.; Schumann, E.; Held, U.; Schwan, M.; Blazevic, M.; Wismüller, A.; Holsboer, F.; Yassouridis, A..; Uhr, M.; Weber, F.; Daumer, M.; Trenkwalder, C.; Auer, D.P. Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis-reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol., 2006, 6, 19.
310. Czuwara-Ladykowska, J.; Sicinska, J.; Olszewska, M.; Uhrynowska-Tyszkiewicz, I.; Rudnicka, L. Prolactin synthesis by lymphocytes from patients with systemic sclerosis. Biomed. Pharmacother., 2006, 60, 152-155.
311. Peeva, E.; Venkatesh, J.; Michael, D.; Diamond, B. Prolactin as a modulator of B cell function: implications for SLE. Biomed. Pharmacother., 2004, 58, 310-319.
312. Jara, L.J.; Vera-Lastra, O.; Miranda, J.M.; Alcala, M.; Alvarez-Nemegyei, J. Prolactin in human systemic lupus erythematosus. Lupus, 2001, 10, 748-756.
313. McMurry, R.W. Prolactin in murine systemic erythematosus. Lupus, 2001, 109, 742-747.
314. Zoli, A.; Lizzio, M.M.; Ferlisi, E.M.; Massafra, V.; Mirone, L.; Barini, A.; Scuderi, F.; Bartolozzi, F.; Magaró, M. ACTH, cortisol and prolactin in active rheumatoid arthritis. Clin. Rheumatol., 2002, 21, 289-293.
315. Sinha, S.; Kaler, L.J.; Proctor, T.M.; Teuscher, C.; Vandenbark, A.A.; Offner, H. IL-13-mediated gender difference in susceptibility to autoimmune encephalomyelitis. J. Immunol., 2008, 180, 2679-2685.
316. Vanbesien, J.; Schiettecatte, J.; Anckaert, E.; Smitz, J.; Velkeniers, B.; De Schepper, J. Circulating anti-prolactin auto-antibodies must be considered in the differential diagnosis of hyperprolactinaemia in adolescents. Eur. J. Pediatr., 2002, 161, 373-376.
317. Gadó, K.; Nagy, G.; Hasitz, A.; Tóth, B.E.; Rimanóczi, E.; Domján, G. Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients. Neuroimmunomodulation, 2001, 9, 95-102.
318. McMurray, R.W. Bromocriptine in rheumatic and autoimmune diseases. Semin. Arthritis Rheum., 2001, 31, 21-32.
319. Walker, S.E. Modulation of hormones in the treatment of lupus Am. J. Manag. Care, 2001, 7(16 Suppl), S486-489.
320. Cruz, J.; Aviña-Zubieta, A.; Martínez de la Escalera, G.; Clapp, C.; Lavalle, C. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus. Arthritis Rheum., 2001, 44(6), 1331-1335.
321. Poyraz, B.C.; Aksoy, C.; Balcioǧlu, I. Increased incidence of auto-immune thyroiditis in patients with antipsychotic-induced hyper-prolactinemia. Eur. Neuropsychopharmacol., 2008, 18, 667-672.
322. Majumder, B.; Biswas, R.; Chattopadhyay, U. Prolactin regulates antitumor immune response through induction of tumoricidal macrophages and release of IL-12. Int. J. Cancer, 2002, 97(4), 493-500.
323. Biswas, R.; Roy, T.; Chattopadhyay, U. Prolactin induced reversal of glucocorticoid mediated apoptosis of immature cortical thymocytes is abrogated by induction of tumor. J. Neuroimmunol. 2006, 171, 120-134.
324. Zhang, J.; Sun, R.; Wei, H.; Tian, Z. Antitumor effects of recombinant human prolactin in human adenocarcinoma-bearing SCID mice with human NK cell xenograft. Int. Immunopharmacol., 2005, 5, 417-425.
325. Dzitko, K.; Malicki, S.; Komorowski, J. Effect of hyperprolactinaemia on Toxoplasma gondii prevalence in humans. Parasitol. Res., 2008, 102, 723-729.
326. Oberbeck, R.; Schmitz, D.; Wilsenack, K.; Schüler, M.; Biskup, C.; Schedlowski, M.; Nast-Kolb, D.; Exton, M.S. Prolactin modulates survival and cellular immune functions in septic mice. J. Surg. Res., 2003, 113, 248-256.
327. Guzmán, E.A.; Langowski, J.L.; De Guzman, A.; Muller, H.K.; Walker, A.M.; Owen, L.B. S179D prolactin diminishes the effects of UV light on epidermal gamma delta T cells. Mol. Cell. Endocrinol., 2008, 280, 6-12.
328. Dugan, A.L.; Schwemberger, S.; Babcock, G.F.; Buckley, D.; Buckley, A.R.; Ogle, C.K.; Horseman, N.D. Effects of prolactin level on burn-induced aberrations in myelopoiesis. Shock, 2004, 21, 151-159.
329. Dugan, A.L.; Thellin, O.; Buckley, D.J.; Buckley, A.R.; Ogle, C.K.; Horseman, N.D. Effects of prolactin deficiency on myelopoiesis and splenic T lymphocyte proliferation in thermally injured mice. Endocrinology, 2002, 143, 4147-4151
330. Gerosa, M.; De Angelis, V.; Riboldi, P.; Meroni, P.L. Rheumatoid arthritis: a female challenge. Womens Health (Lond. Engl.)., 2008, 4, 195-201.
331. Morales-Montor, J.; Escobedo, G.; Vargas-Villavicencio, J.A.; Larralde, C. The neuroimmunoendocrine network in the complex host-parasite relationship during murine cysticercosis. Curr. Top. Med. Chem., 2008, 8, 400-407.
332. Shuster, E.A. Hormonal influences in multiple sclerosis. Curr. Top. Microbiol. Immunol., 2008, 318, 267-311.
333. Bynoté, K.K.; Hackenberg, J.M.; Korach, K.S.; Lubahn, D.B.; Lane, P.H.; Gould, K.A. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice. Genes Immun., 2008, 9, 137-152.
334. Bird, M.D.; Karavitis, J.; Kovacs, E.J. Sex differences and estrogen modulation of the cellular immune response after injury. Cell. Immunol., 2008, 252, 57-67.
335. Choudhry, M.A.; Chaudry, I.H. 17beta-Estradiol: a novel hormone for improving immune and cardiovascular responses following trauma-hemorrhage. J. Leukoc. Biol., 2008, 83, 518-522.
336. Arnal, J.F.; Laurell, H.; Lenfant, F.; Douin-Echinard, V.; Brouchet, L.; Gourdy, P. Estradiol action in atherosclerosis and reendothelialization. Ernst Schering Found. Symp. Proc., 2006, 1, 69-86.
337. Straub, R.H. The complex role of estrogens in inflammation. Endocr. Rev., 2007, 28, 521-574.
338. Cutolo, M.; Capellino, S.; Straub, R.H. Oestrogens in rheumatic diseases: friend or foe? Rheumatology (Oxford), 2008, 47(Suppl. 3), iii2-5.
339. Orbach, H.; Shoenfeld, Y. Hyperprolactinemia and autoimmune diseases. Autoimmun. Rev., 2007, 6, 537-542.
340. Tiwari-Woodruff, S.; Morales, L.B.; Lee, R.; Voskuhl, R.R. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc. Natl. Acad. Sci. USA, 2007, 104, 14813-14818.
341. Jara, L.J.; Navarro, C.; Medina, G.; Vera-Lastra, O.; Blanco, F. Immune-neuroendocrine interactions and autoimmune diseases. Clin. Dev. Immunol., 2006, 13, 109-123.
342. Austad, S.N. Why women live longer than men: sex differences in longevity. Gend. Med., 2006, 3, 79-92.
343. Fimmel, S.; Zouboulis, C.C. Influence of physiological androgen levels on wound healing and immune status in men. Aging Male, 2005, 8, 166-174.
344. Cutolo, M.; Sulli, A.; Seriolo, B. Estrogens, autoimmunity and the heart. Lupus, 2005, 14, 675-678.
345. Cutolo, M.; Lahita, R.G. Estrogens and arthritis. Rheum. Dis. Clin. North Am., 2005, 31, 19-27, vii.
346. Szyper-Kravitz, M.; Zandman-Goddard, G.; Lahita, R.G.; Shoenfeld, Y. The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity. Rheum. Dis. Clin. North Am., 2005, 31, 161-175.
347. Arnal, J.F.; Gourdy, P.; Elhage, R.; Garmy-Susini, B.; Delmas, E.; Brouchet, L.; Castano, C.; Barreira, Y.; Couloumiers, J.C.; Prats, H.; Prats, A.C.; Bayard, F. Estrogens and atherosclerosis. Eur. J. Endocrinol., 2004, 150, 113-117.
348. Engdahl, C.; Jochems, C.; Windahl, S.H.; Börjesson, A.E.; Ohlsson, C.; Carlsten, H.; Lagerquist, M.K. Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30. Arthritis Rheum., 2010, 62, 524-533.
349. Feng, F.; Nyland, J.; Banyai, M.; Tatum, A.; Silverstone, A.E.; Gavalchin, J. The induction of the lupus phenotype by estrogen is via an estrogen receptor-alpha-dependent pathway. Clin. Immunol., 2010, 134, 226-236.
350. Polanczyk, M.J.; Jones, R.E.; Subramanian, S.; Afentoulis, M.; Rich, C.; Zakroczymski, M.; Cooke, P.; Vandenbark, A.A.; Offner, H. T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis. Am. J. Pathol., 2004, 165, 2069-2077.
351. Garidou, L.; Laffont, S.; Douin-Echinard, V.; Coureau, C.; Krust, A.; Chambon, P.; Guéry, J.C. Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol., 2004, 173, 2435-2442.
352. Shim, G.J.; Kis, L.L.; Warner, M.; Gustafsson, J.A. Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc. Natl. Acad. Sci. USA, 2004, 101, 1720-1724.
353. Liu, H.B.; Loo, K.K.; Palaszynski, K.; Ashouri, J.; Lubahn, D.B.; Voskuhl, R.R. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J. Immunol., 2003, 171, 6936-6940.
354. Törnwall, J.; Carey, A.B.; Fox, R.I.; Fox, H.S. Estrogen in auto-immunity: expression of estrogen receptors in thymic and autoimmune T cells. J. Gend. Specif. Med., 1999, 2, 33-40.
355. Polanczyk, M.; Yellayi, S.; Zamora, A.; Subramanian, S.; Tovey, M.; Vandenbark, A.A.; Offner, H.; Zachary, J.F.; Fillmore, P.D.; Blankenhorn, E.P.; Gustafsson, J.A.; Teuscher, C. Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice. Am. J. Pathol., 2004, 164, 1915-1924.
356. Piotrowski, P.; Gasik, R.; Lianeri, M.; Cieślak, D.; Wudarski, M.; Hrycaj, P.; Łacki, J.K.; Agodziński, P.P. Asp327Asn polymorphism of sex hormone-binding globulin gene is associated with systemic lupus erythematosus incidence. Mol. Biol. Rep., 2010, 37, 235-239.
357. Matejuk, A.; Dwyer, J.; Hopke, C.; Vandenbark, A.A.; Offner, H. 17Beta-estradiol treatment profoundly down-regulates gene expression in spinal cord tissue in mice protected from experimental auto-immune encephalomyelitis. Arch. Immunol. Ther. Exp. (Warsz.), 2003, 51, 185-193.
358. Hosoda, T.; Mito, N.; Yoshino, H.; Sato, K. Estrogen altered oral tolerance induction in type II collagen-induced murine arthritis. Int. Arch. Allergy Immunol., 2004, 133, 19-28.
359. Rodriguez, E.; Guevara, J.; Paez, A.; Zapata, E.; Collados, M.T.; Fortoul, T.I.; Lopez-Marure, R.; Masso, F.; Montaño, L.F. The altered expression of inflammation-related molecules and secretion of IL-6 and IL-8 by HUVEC from newborns with maternal inactive systemic lupus erythematosus is modified by estrogens. Lupus, 2008, 17, 1086-1095.
360. Chapman, J.C.; Min, S.H.; Freeh, S.M.; Michael, S.D. The estrogen-injected female mouse: new insight into the etiology of PCOS. Reprod. Biol. Endocrinol., 2009, 18, 7-47.
361. Voskuhl, R.R. Hormone-based therapies in MS. Int. MS J., 2003, 10, 60-66.
362. Delpy, L.; Douin-Echinard, V.; Garidou, L.; Bruand, C.; Saoudi, A.; Guéry, J.C. Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J. Immunol., 2005, 175, 5050-5057.
363. Ganesan, K.; Balachandran, C.; Manohar, B.M.; Puvanakrishnan, R. Comparative studies on the interplay of testosterone, estrogen and progesterone in collagen induced arthritis in rats. Bone, 2008, 43, 758-765.
364. Santora, K.; Rasa, C.; Visco, D.; Steinetz, B.G.; Bagnell, C.A. Antiarthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis J. Pharmacol. Exp. Ther., 2007, 322, 887-893.
365. Yoneda, T.; Ishimaru, N.; Arakaki, R.; Kobayashi, M.; Izawa, T.; Moriyama, K.; Hayashi, Y. Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. Endocrinology, 2004, 145, 2384-2391.
366. Jochems, C.; Islander, U.; Erlandsson, M.; Verdrengh, M.; Ohlsson, C.; Carlsten, H. Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation. Arthritis Res. Ther., 2005, 7, R837-843.
367. Rovensky, J.; Radikova, Z.; Imrich, R.; Greguska, O.; Vigas, M.; Macho, L. Gonadal and adrenal steroid hormones in plasma and synovial fluid of patients with rheumatoid arthritis. Endocr. Regul., 2004, 38, 143-149.
368. Castagnetta, L.A.; Carruba, G.; Granata, O.M.; Stefano, R.; Miele, M.; Schmidt, M.; Cutolo, M.; Straub, R.H. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J. Rheumatol., 2003, 30, 2597-2605.
369. Bao, M.; Yang, Y.; Jun, H.S.; Yoon, J.W. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol., 2002, 168, 5369-5375.
370. Doria, A.; Cutolo, M.; Ghirardello, A.; Zampieri, S.; Vescovi, F.; Sulli, A.; Giusti, M.; Piccoli, A.; Grella, P.; Gambari, P.F. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum., 2002, 47, 202-209.
371. Palaszynski, K.M.; Liu, H.; Loo, K.K.; Voskuhl, R.R. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol., 2004, 149, 84-89.
372. Morales, L.B.; Loo, K.K.; Liu, H.B.; Peterson, C.; Tiwari-Woodruff, S.; Voskuhl, R.R. Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J. Neurosci., 2006, 26, 6823-6833.
373. Li, J.; McMurray, R.W. Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model. Clin. Immunol., 2007, 123, 219-226.
374. Elloso, M.M.; Phiel, K.; Henderson, R.A.; Harris, H.A.; Adelman, S.J. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. J. Endocrinol., 2005, 185, 243-252.
375. Sthoeger, Z.M.; Zinger, H.; Mozes, E. Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies. Ann. Rheum. Dis., 2003, 62, 341-346.
376. Hiramoto, K.; Tanaka, H.; Yanagihara, N.; Sato, E.F.; Inoue, M. Effect of 17beta-estradiol on immunosuppression induced by ultraviolet B irradiation. Arch. Dermatol. Res. 2004, 295, 307-311.
377. Frantz, M.C.; Prix, N.J.; Wichmann, M.W.; van den Engel, N.K.; Hernandez-Richter, T.; Faist, E.; Chaudry, I.H.; Jauch, K.W.; Angele, M.K. Dehydroepiandrosterone restores depressed peripheral blood mononuclear cell function following major abdominal surgery via the estrogen receptors. Crit. Care Med., 2005, 33, 1779-1786.
378. Samy, T.S.; Zheng, R.; Matsutani, T.; Rue, L.W. 3rd.; Bland, K.I.; Chaudry, I.H. Mechanism for normal splenic T lymphocyte functions in proestrus females after trauma: enhanced local synthesis of 17beta-estradiol. Am. J. Physiol. Cell. Physiol., 2003, 285, C139-149.
379. Hsieh, Y.C.; Frink, M.; Thobe, B.M.; Hsu, J.T.; Choudhry, M.A.; Schwacha, M.G.; Bland, K.I.; Chaudry, I.H. 17Beta-estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhage. Mol. Immunol., 2007, 44, 2165-2172.
380. Frink, M.; Hsieh, Y.C.; Hu, S.; Hsieh, C.H.; Pape, H.C.; Choudhry, M.A.; Schwacha, M.G.; Bland, K.I.; Chaudry, I.H. Mechanism of salutary effects of finasteride on post-traumatic immune/inflammatory response: upregulation of estradiol synthesis. Ann. Surg., 2007, 246, 836-843.
381. Hsieh, Y.C.; Frink, M.; Choudhry, M.A.; Bland, K.I.; Chaudry, I.H. Metabolic modulators following trauma sepsis: sex hormones. Crit. Care Med., 2007, 35(9 Suppl), S621-629.
382. Hildebrand, F.; Hubbard, W.J.; Choudhry, M.A.; Thobe, B.M.; Pape, H.C.; Chaudry, I.H. Are the protective effects of 17beta-estradiol on splenic macrophages and splenocytes after trauma-hemorrhage mediated via estrogen-receptor (ER)-alpha or ER-beta? J. Leukoc. Biol., 2006, 79, 1173-1180.
383. Kovacs, E.J.; Plackett, T.P.; Witte, P.L. Estrogen replacement, aging, and cell-mediated immunity after injury. J. Leukoc. Biol., 2004, 76, 36-41.
384. Dienstknecht, T.; Schwacha, M.G.; Kang, S.C.; Rue, L.W.; Bland, K.I.; Chaudry, I.H. Sex steroid-mediated regulation of macrophage/monocyte function in a two-hit model of trauma-hemorrhage and sepsis. Cytokine, 2004, 25, 110-118.
385. Mees, S.T.; Dohm, C.; Broetzmann, K.; Schroeder, J.; Faendrich, F.; Kremer, B.; Kahlke, V. Age- and gender-related differences of the immune function in a murine model of hemorrhagic shock: IL-10 restores immunodepression in aged females without reduction of mortality. Langenbecks Arch. Surg., 2007, 392, 629-638.
386. Plackett, T.P.; Oz, O.K.; Simpson, E.R.; Kovacs, E.J. Lack of aromatase improves cell-mediated immune response after burn. Burns, 2006, 32, 577-582.
387. Osorio, Y.; Bonilla, D.L.; Peniche, A.G.; Melby, P.C.; Travi, B.L. Pregnancy enhances the innate immune response in experimental cutaneous leishmaniasis through hormone-modulated nitric oxide production. J. Leukoc. Biol., 2008, 83, 1413-1422.
388. Libonati, R.M.; Cunha, M.G.; Souza, J.M.; Santos, M.V.; Oliveira, S.G.; Daniel-Ribeiro, C.T.; Carvalho, L.J.; do Nascimento, J.L. Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice. Neuroimmunomodulation, 2006, 13, 28-35.
389. Escribese, M.M.; Kraus, T.; Rhee, E.; Fernandez-Sesma, A.; López, C.B.; Moran, T.M. Estrogen inhibits dendritic cell maturation to RNA viruses. Blood, 2008, 112, 4574-4584.
390. Ramos, A.M.; Perazzio, S.; Camargos, A.F.; Pereira, F.E. Spontaneous inflammatory pelvic disease in adult non-castrated female rats treated with estrogen. Braz. J. Infect. Dis., 2005, 9, 6-8.
391. Khan, K.N.; Kitajima, M.; Hiraki, K.; Fujishita, A.; Sekine, I.; Ishimaru, T.; Masuzaki, H. Immunopathogenesis of pelvic endometriosis: role of hepatocyte growth factor, macrophages and ovarian steroids. Am. J. Reprod. Immunol., 2008, 60, 383-404.
392. Elenkov, I.J.; Wilder, R.L.; Bakalov, V.K.; Link, A.A.; Dimitrov, M.A.; Fisher, S.; Crane, M.; Kanik, K.S.; Chrousos, G.P. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J. Clin. Endocrinol. Metab., 2001, 86, 4933-4938.
393. Itsekson, A.M.; Seidman, D.S.; Zolti, M.; Lazarov, A.; Carp, H.J. Recurrent pregnancy loss and inappropriate local immune response to sex hormones. Am. J. Reprod. Immunol., 2007, 57, 160-165.
394. Cunningham, T.D.; Jiang, X.; Shapiro, D.J. Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity. Cell. Immunol., 2007, 245, 32-41.
395. Macho, L.; Rovensky, J.; Kvetnansky, R.; Radikova, Z.; Fickova, M.; Zorad, S. Hormone response to stress in rat strains of different susceptibility to immunologic challenge. Endocr. Regul., 2008, 42, 23-28.
396. Kovacs, E.J.; Faunce, D.E.; Messingham, K.A. Ethanol and burn injury: estrogen modulation of immunity. Alcohol, 2004, 33, 209-216.
397. Jiang, X.; Orr, B.A.; Kranz, D.M.; Shapiro, D.J. Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells. Endocrinology, 2006, 147, 1419-1426.
398. Check, J.H.; Dix, E.; Sansoucie, L. Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein. Med. Hypotheses, 2009, 72, 87-90.
399. Arck, P.; Hansen, P.J.; Mulac Jericevic, B.; Piccinni, M.P.; Szekeres-Bartho, J. Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am. J. Reprod. Immunol., 2007, 58, 268-279.
400. Ragusa, A.; de Carolis, C.; dal Lago, A.; Miriello, D.; Ruggiero, G.; Brucato, A.; Pisoni, M.P.; Muscarà, M.; Merati, R.; Maccario, L.; Nobili, M. Progesterone supplement in pregnancy: an immunologic therapy? Lupus, 2004, 13, 639-642.
401. Peltier, M.R. Immunology of term and preterm labor. Reprod. Biol. Endocrinol., 2003, 1, 122.
402. Mitchell, V.L.; Gershwin, L.J. Progesterone and environmental tobacco smoke act synergistically to exacerbate the development of allergic asthma in a mouse model. Clin. Exp. Allergy, 2007, 37, 276-286.
403. Pettus, E.H.; Wright, D.W.; Stein, D.G.; Hoffman, S.W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res., 2005, 1049, 112-119.
404. Hoffman, G.E.; Le, W.W.; Murphy, A.Z.; Koski, C.L. Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats. Exp. Neurol., 2001, 171, 272-284.
405. Elovitz, M.A.; Gonzalez, J. Medroxyprogesterone acetate modulates the immune response in the uterus, cervix and placenta in a mouse model of preterm birth. J. Matern. Fetal Neonatal Med., 2008, 21, 223-230.
406. Joachim, R.; Zenclussen, A.C.; Polgar, B.; Douglas, A.J.; Fest, S.; Knackstedt, M.; Klapp, B.F.; Arck, P.C. The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids, 2003, 68, 931-940.
407. Blois, S.M.; Joachim, R.; Kandil, J.; Margni, R.; Tometten, M.; Klapp, B.F.; Arck, P.C. Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dy-drogesterone in mice by altering the Th1/Th2 cytokine profile. J. Immunol., 2004, 172, 5893-5899.
408. Szekeres-Bartho, J.; Barakonyi, A.; Par, G.; Polgar, B.; Palkovics, T.; Szereday, L. Progesterone as an immunomodulatory molecule. Int. Immunopharmacol., 2001, 1, 1037-1048.
409. Szekeres-Bartho, J.; Balasch, J. Progestagen therapy for recurrent miscarriage. Hum. Reprod. Update, 2008, 14, 27-35.
410. Forneris, M.; Rosales, E.; Ciuffo, G.; Oliveros, L. Testosterone environment of splenocytes modifies the steroidogenesis of polycystic ovary in rats. Horm. Metab. Res., 2008, 40, 239-244.
411. Vargas-Villavicencio, J.A.; Larralde, C.; De León-Nava, M.A.; Morales-Montor, J. Regulation of the immune response to cestode infection by progesterone is due to its metabolism to estradiol. Microbes Infect., 2005, 7, 485-493.
412. Kaushic, C.; Ashkar, A.A.; Reid, L.A.; Rosenthal, K.L. Progester-one increases susceptibility and decreases immune responses to genital herpes infection. J. Virol., 2003, 77, 4558-4565.
413. Trunova, N.; Tsai, L.; Tung, S.; Schneider, E.; Harouse, J.; Gettie, A.; Simon, V.; Blanchard, J.; Cheng-Mayer, C. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology, 2006, 352, 169-177.
414. Kaushic, C.; Zhou, F.; Murdin, A.D.; Wira, C.R. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 2000, 68, 4207-4216.
415. Devonshire, V.; Duquette, P.; Dwosh, E.; Guimond, C. The immune system and hormones: review and relevance to pregnancy and contraception in women with MS. Int. MS. J., 2003, 10, 44-50.
416. Yilmazer, M.; Fenkci, V.; Fenkci, S.; Aktepe, O.; Sonmezer, M.; Kurtay, G. Association of serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels with hormone replacement therapy in healthy post-menopausal women. Hum. Reprod., 2003, 18, 1531-1535.
417. Holroyd, C.R.; Edwards, C.J. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus. Climacteric, 2009, 12, 378-386.
418. Berg, G.; Ekerfelt, C.; Hammar, M.; Lindgren, R.; Matthiesen, L.; Ernerudh, J. Cytokine changes in postmenopausal women treated with estrogens: a placebo-controlled study. Am. J. Reprod. Immunol., 2002, 48, 63-69.
419. Saucedo, R.; Rico, G.; Basurto, L.; Ochoa, R.; Zárate, A. Transdermal estradiol in menopausal women depresses interleukin-6 without affecting other markers of immune response. Gynecol. Obstet. Invest., 2002, 53, 114-117.
420. Rachoń, D.; Suchecka-Rachoń, K.; Hak, Ł.; Myśliwska, J. Effects of intranasal 17beta-estradiol administration on serum bioactive in-terleukin-6 and C-reactive protein levels in healthy postmenopausal women. Menopause, 2006, 13, 840-845.
421. Attanasio, R.; Gust, D.A.; Wilson, M.E.; Meeker, T.; Gordon, T.P. Immunomodulatory effects of estrogen and progesterone replacement in a nonhuman primate model. J. Clin. Immunol., 2002, 22, 263-269.
422. Stopińska-Głuszak, U.; Waligóra, J.; Grzela, T.; Głuszak, M.; Jóźwiak, J.; Radomski, D.; Roszkowski, P.I.; Malejczyk, J. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J. Reprod. Immunol., 2006, 69, 65-75.
423. Dogan, E.; Erkoc, R.; Demir, C.; Sayarlioglu, H.; Dilek, I.; Sayarlioglu, M. Effect of hormone replacement therapy on CD4+ and CD8+ numbers, CD4+/CD8+ ratio, and immunoglobulin levels in hemodialysis patients. Ren. Fail., 2005, 27, 421-424.
424. d'Elia, H.F.; Carlsten, H. The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis. Scand. J. Immunol., 2008, 68, 661-667.
425. Critchley, H.O.; Kelly, R.W.; Brenner, R.M.; Baird, D.T. The endocrinology of menstruation--a role for the immune system. Clin. Endocrinol. (Oxf)., 2001, 55, 701-710.
426. Vukusic, S.; Ionescu, I.; El-Etr, M.; Schumacher, M.; Baulieu, E.E.; Cornu, C.; Confavreux, C. The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J. Neurol. Sci., 2009, 286, 114-118.
427. Khan, W.A.; Uddin, M.; Khan, M.W.; Chabbra, H.S. Catecholoestrogens: possible role in systemic lupus erythematosus. Rheumatology, (Oxford), 2009, 48, 1345-1351.
428. Gold, S.M.; Sasidhar, M.V.; Morales, L.B.; Du, S.; Sicotte, N.L.; Tiwari-Woodruff, S.K.; Voskuhl, R.R. Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha). Lab. Invest. 2009, 89(10), 1076-1083.
429. Soldan, S.S.; Alvarez Retuerto, A.I.; Sicotte, N.L.; Voskuhl, R.R Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol., 2003, 171, 6267-6274.
430. Matejuk, A.; Hopke, C.; Vandenbark, A.A.; Hurn, P.D.; Offner, H. Middle-age male mice have increased severity of experimental autoimmune encephalomyelitis and are unresponsive to testosterone therapy. J. Immunol., 2005, 174, 2387-2395.
431. Bebo, B.F. Jr.; Fyfe-Johnson, A.; Adlard, K.; Beam, A.G.; Vandenbark, A.A.; Offner, H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol., 2001, 166, 2080-2089.
432. Lee, H.M.; Mima, T.; Sugino, H.; Aoki, C.; Adachi, Y.; Yoshio-Hoshino, N.; Matsubara, K.; Nishimoto, N. Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus. Arthritis Res. Ther., 2009, 11, R1.
433. Ottonello, L.; Frumento, G.; Arduino, N.; Bertolotto, M.; Mancini, M.; Sottofattori, E.; Dallegri, F.; Cutolo, M. Delayed neutrophil apoptosis induced by synovial fluid in rheumatoid arthritis: role of cytokines, estrogens, and adenosine. Ann. N.Y. Acad. Sci., 2002, 966, 226-231.
434. García-Pérez, M.A.; Del Val, R.; Noguera, I.; Hermenegildo, C.; Pineda, B.; Martinez-Romero, A.; Cano, A. Estrogen receptor agonists and immune system in ovariectomized mice. Int. J. Immunopathol. Pharmacol., 2006, 19, 807-819.
435. Gillgrass, A.E.; Tang, V.A.; Towarnicki, K.M.; Rosenthal, K.L.; Kaushic, C. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue. J. Virol., 2005, 79, 3117-3126.
436. Turchan, J.; Anderson, C.; Hauser, K.F.; Sun, Q.; Zhang, J.; Liu, Y.; Wise, P.M.; Kruman, I.; Maragos, W.; Mattson, M.P.; Booze, R.; Nath, A. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci., 2001, 2, 3.
437. Sugiura, K.; Nishikawa, M.; Ishiguro, K.; Tajima, T.; Inaba, M.; Torii, R.; Hatoya, S.; Wijewardana, V.; Kumagai, D.; Tamada, H.; Sawada, T.; Ikehara, S.; Inaba, T. Effect of ovarian hormones on periodical changes in immune resistance associated with estrous cycle in the beagle bitch. Immunobiology, 2004, 209, 619-627.
438. Harnish, D.C.; Albert, L.M.; Leathurby, Y.; Eckert, A.M.; Ciarletta, A.; Kasaian, M.; Keith, J.C. Jr. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease. Am. J. Physiol. Gastrointest. Liver Physiol., 2004, 286, G118-125.
439. Suzuki, T.; Shimizu, T.; Yu, H.P.; Hsieh, Y.C.; Choudhry, M.A.; Schwacha, M.G.; Chaudry, I.H. Tissue compartment-specific role of estrogen receptor subtypes in immune cell cytokine production following trauma-hemorrhage. J. Appl. Physiol. 2007, 102, 163-168.
440. Coleman, I.M.; Kiefer, J.A.; Brown, L.G.; Pitts, T.E.; Nelson, P.S.; Brubaker, K.D.; Vessella, R.L.; Corey, E. Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes. Neoplasia, 2006, 8, 862-878.
441. Jiang, X.; Ellison, S.J.; Alarid, E.T.; Shapiro, D.J. Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene, 2007, 26, 4106-4114.
442. Morales-Montor, J.; Baig, S.; Mitchell, R.; Deway, K.; Hallal-Calleros, C.; Damian, R.T. Immunoendocrine interactions during chronic cysticercosis determine male mouse feminization: role of IL-6. J. Immunol., 2001, 167, 4527-4533.
443. Cutolo, M.; Montagna, P.; Brizzolara, R.; Sulli, A.; Seriolo, B.; Villaggio, B.; Triolo, P.; Clerico, P.; Soldano, S. Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients. J. Autoimmun., 2009, 32, 254-260.
444. Berczi, I. Integration and regulation of higher organisms by the neuroimmune supersystem. Int. J. Integr. Biol., 2007, 1, 216-231.
445. Berczi, I. Antigenic recognition by the brain. The brain as an immunocompetent organ. In New Insights to Neuroimmune Biology. Berczi, I. Ed. Elsevier, Amsterdam, 2010, pp. 145-159. Elsevier, Insights, www.amazon.com
446. Berczi, I.; Quinatanar-Stephano, A.; Kovacs, K. The brave new world of Neuroimmne Biology. In New Insights to Neuroimmune Biology. Berczi, I. Ed. Elsevier, Amsterdam, 2010, pp. 3-30 Elsevir, Insights. www.amazon.com
447. Sioud, M. Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines? Scand. J. Immunol. 2009, 70, 516-525.
448. Sanguansermsri, D.; Pongcharoen, S. Pregnancy immunology: decidual immune cells. Asian Pac. J. Allergy Immunol., 2008, 26, 171-181.
449. Makrigiannakis, A.; Karamouti, M.; Drakakis, P.; Loutradis, D.; Antsaklis, A. Fetomaternal immunotolerance. Am. J. Reprod. Immunol., 2008, 60, 482-496.
450. Knöfler, M. Critical growth factors and signaling pathways controlling human trophoblast invasion. Int. J. Dev. Biol., 2010, 54, 269-280.
451. Schmidt, K.L.; Pradhan, D.S.; Shah, A.H..; Charlier, T.D.; Chin, E.H.; Soma, K.K. Neurosteroids, immunosteroids, and the Balkanization of endocrinology. Gen. Comp. Endocrinol., 2008, 157, 266-274.
452. Berczi, I.; Szentivanyi, A. The immune-neuroendocrine circuitry. In Neuroimmmune Biology: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi, I.; Szentivanyi, A., Eds, Elsevier, Amsterdam, 2003; Vol. 3, pp. 561-592.
453. Berczi, I.; Quintanar-Stephano, A.; Kovacs, K. Neuroimmune regulation in immunocompetence, acute illness, and healing. Ann. NY Acad. Sci., 2009, 1153, 220-239.
454. Bebo, B.F. Jr.; Dehghani, B.; Foster, S.; Kurniawan, A.; Lopez, F.J.; Sherman, L.S. Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis. Glia, 2009, 57, 777-790.
455. Cutolo, M. Hormone therapy in rheumatic diseases. Curr. Opin. Rheumatol., 2010, 22, 257-263.
456. McKay, D.M.; Bienenstock, J. The interaction between must cells and nerves in the gastrointestinal tract. Immunol. Today, 1994, 15, 553-568.
457. Conti, B.; Tabarean, I.; Sanches-Alavez, M.; Davis C.; Brownell, S.; Behrens, M.; Bartfai, T. Cytokine receptors in the brain. In Cytokines and the Brain. Neuroimmune Biology, vol. 6. Phelps, C.; Korneva, E. Eds. Berczi, I.; Szentivanyi, A. Series Eds. Elsevier, Amsterdam. 2008, pp. 21-38.